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Drug Frauds are on the increase, falsified drugs are giving sleepless nights 
to both patients, healthcare professionals as well governments of different 
countries, and thus the regulation prohibiting the sales and production of falsified 
drugs cannot succeed with any form technological intervention. The study aims 
to evaluate several criteria that as contributed to the challenges of identifying 
falsified drugs among healthcare professionals- medical doctors, pharmacists, 
and other healthcare professionals in Nigeria. Through a questionnaire-based 
survey and phone interview for both the quantitative and qualitative analyses, 
respectively a review would be done. For this to be achieved the knowledge, 
awareness, and possible challenges faced by the professionals concerning 
falsified drug identification were considered to recommend an effective 
recommendation on different ways to improve such practice of 
pharmacovigilance in Nigeria. 
 In this thesis all the groups of healthcare professionals a comparison was 
made to ascertain different opinions on frequency observed on falsified drugs, 
ways of detecting falsified drugs, the technology used in identifying falsified drugs, 
as well as regulatory agency responsible for reporting of falsified drugs in Nigeria. 
A total of 131 responded to the survey of whom 62 (45.80%) were medical doctors 
and 43 (32.82%) were pharmacists as well as 43 (32.82%) were other healthcare 
professionals. 
 It was fascinating to see that 62% of the respondents agreed to the fact 
that they know how to identify falsified drugs (40 medical doctors, others 18, 
pharmacist 23) while 42%(13 medical doctors, others 17, pharmacist 12) of the 
respondents did not know. Only 6% of the healthcare professionals (7 medical 
doctors, 1 pharmacist) are not sure if they can detect fake drugs in Nigeria. From 
the study conducted it was unfortunate to note that pharmacists had average 
knowledge, awareness in comparison to a medical doctor who had better 
awareness of the in identifying fake drugs. However, 95% of all the respondents all 
agreed that identifying falsified drugs and reporting it should be made 
compulsory as part of the way of upgrading pharmacovigilance in Nigeria. 
Some of the challenges that all respondents majorly agreed to are 
inadequate existing laws, ignorance among healthcare professionals, presence 
of non-health professionals in the health sector business, high cost of quality drugs, 
and finally the high level of corruption. All respondents also agreed that 
continuous learning can create more awareness of the challenges of falsified 
drugs, including heavy fines and sanctions on defaulters and also creating a 
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special department that would be tasked with the responsibility of monitoring 
falsified drugs in the market. 
Key Words: Falsified drugs Identification: Knowledge, awareness and challenges, 
pharmacovigilance, identification system, Mobile Authentication System (MAS), TruScan, Radio 
Frequency Identification (RFI), Blackeye, healthcare professionals, Nigeria Agency for Food and 
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CHAPTER 1: INTRODUCTION  
1.1 OVERVIEW 
“The art of medicine consists of amusing the patient while drugs cure the 
disease”- Volatire 
The production and trading of falsified drugs in treating an adverse form of 
life-threatening conditions have been documented as one of the major issues 
contributing to the high rate of mortality and so much loss of confidence by the 
public and private sector concerning the Nigerian health sector. Hence falsified 
drugs are the product that is not original and authentic due to its production of 
using inaccurate quantities or ingredients to reduce its potency as well as 
neutralize the effect of the drugs. Documented report as shown that fake and 
substandard drugs as contributed greatly to different range of adverse forms of 
effect ranging from severe internal and external injury of the body system and 
organs, disability, paralysis, and serious complications which can lead to death. 
(Blackstone et al., 2014) 
The issue of a falsified drug is a worldwide pandemic, this is because the 
effects can be felt from where the drug was produced to the countries where it 
is been supplied. Hence due to the most sophisticated means by which these 
offenders are going about their trade, it has been difficult for the various country 
to put measures that would end these crises. (Rae Ellen 2017) 
Therefore, Nigeria is never an exception to this problem of falsified drugs 
which is ongoing at the moment. In so doing some people still have confidence 
in self-medication to treat themselves when they are ill, and in most cases, this 
drug is bought from vendors without any form of license to operate. In the last two 
decades, the problem of the falsified drug has been a very concerning issue 
which contributed to the death of over 150 children who died in 1989 due to a 
major error in the formulation. This was, in fact, a move that led to the 
establishment of NAFDAC which was tasked with the responsibility of tackling the 
issues of fake drugs. The main purpose was to ensure good, safe, and effective 
drugs were registered with the highest form of quality of drugs that is less expensive 
and cost-effective. (NAFDAC 2019) 
In April 2001, the director-general of NAFDAC, Professor Dora Akunyili in 
fighting the issues of sale of falsified  drugs worked hard to implement policy that 
would protect the drug market, but yet the presence of such continues and this 
makes me ponder the reason why. The ultimate questions are why does Nigeria 
still operate an open drug market system? Why do Nigerians in drug business 
breach the stipulated drug laws and regulation and still get away with it which 
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always lead to mass murder and more money to the banks of the offenders? To 
what time frame can healthcare professionals fight the battle of a falsified drug? 
All of which would be answered as we go along this study. 
The continuous effect of major firms and organizations that deal with fake 
drugs and bridge the laid down laws and regulations, as assisted in reducing the 
falsified  drug sales, however when things seem as if it’s getting better different 
forms of illegal drug business will surface. I then wonder again, could it be that the 
agency itself is not doing so much to stop this evil activity, or could the major issues 
be from those who are selling these drugs themselves. 
However, there is a need to maintain the highest form of drug quality and 
standards which is in line with very strict rules and guidelines that are enforced 
during the clinical trial phase and post-authorization. As we are all aware before 
a drug is certified it goes through various clinical trials from Phase 1 to Phase 4 
before it enters the market to be sold to the public. 
 
 




Figure 2: Pharmacovigilance in Phase 4 
 Over the years in response to good pharmacovigilance practice the 
agency as devised various means of assisting the health workers in combating the 
challenges of identifying falsified drugs. According to NAFDAC News (2013, p.11) 
“initially, the most common process that was developed by NAFDAC was the 
process of using the NAFDAC Registration Number on the product package for 
spontaneous identification of falsified drugs in Nigeria”. This led to the replication 
of fastmoving drugs to becoming the perfect business for most people even the 
original owners find it very hard to differentiate between fake and original. The 
health care professionals have been faced with challenges that as affected them 
in effectively identifying fake drugs due to the cloning process of these registration 
numbers that are been attached to the packages of the drugs as a result, they 
lose the battle every day due to the smartness of the offenders. (NAFDAC 2019) 
 Thus, is against these setbacks and the movement towards achieving the 
then-presidential target of no tolerance that the agency came up with various 
forms of technology. The objectives of these cutting-edge technologies were to 
assist healthcare professionals in spontaneous identifying of a falsified drug in the 
country and discourage the activities of those involved in drug falsification. 
(NAFDAC 2019) 
 Some of the anti-falsification system that were introduced include. 
 Truscan: it is a device that generally uses the principle of Rahman’s 
Spectroscopy to test the identity of a product in just one minute. With the 
help of the Truscan, it was possible to scan imported products at the ports 
of entry before it reaches the market without necessarily affecting the 
quality of the drug. (Vanguardngr, 2011)  
 Black Eye: NAFDAC adopted this form of technology from the Israeli 
government a country that is very good at security instruments. It considers 
the same working principle as Truscan which depends on active 
thermography. Its working principle is very essential because it is a non-
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destructive process. It works by comparing the medicinal drug that is under 
investigation to check whether it is more of a genuine product or fake. 
What the machine does is that it breaks down the component of the drugs 
and then tell you it active pharmaceutical composition or its inactive 
pharmaceutical ingredients (Vanguardngr, 2011). It is a faster means 
because the Black Eye allows thousands of tablets to be tested at the same 
time and it will test each one giving the chemical composition.  
 Radio Frequency Identification (RFID): This involves the use of radio waves 
to verify data that is embedded on a tag attached to the medicinal 
products. The tag can, therefore, be read from up to distance away and 
does not involve the product in the line of the reader to be tracked. To read 
the data encoded on a tag, an interrogator then emits a signal to the tag 
using an antenna which reflects the result on the RFID computer system. 
(EPC-RFID 2020) 
 Mobile Authentication Service (MAS): Since 2010 NAFDAC then deployed 
a mobile authentication service as another strategy in detecting 
substandard and falsified medicinal products. it uses a scratch code and 
short messaging service to enlighten and empower does who consume the 
medicinal products. With the aid of short codes and short messaging 
service to verify the originality of the products that were purchase. The 
consumer will first scratch a panel on the product which should reveal a 
unique one-time pin. The PIN is then sent toll-free to a short code using any 
of the GSM operators such as GLO, MTN, or Airtel and in return, the 
consumer receives a response stating if the product is genuine or not. 
(Akunyili 2010) 
The awareness of all healthcare workers towards spontaneous identification 
and reporting of falsified drugs where instinctively positive to the system, the 
implementation of practicing the idea of spontaneous reporting when the fake 
drugs have been identified remain a serious issue to be solved. Little or no 
knowledge of proper guidelines and regulations, indecision as to who takes the 
responsibility of reporting among health care professionals, lack of good 
government policy concern drug regulations, poor network, lack of funding in the 
health care department resulting to most doctors and pharmacist trying to cut 
corners all in one way or the other contributes to the inefficiency of identifying 
and reporting falsified drugs before its get to the citizens. 
The author's purpose for this study is to carry out a valuation with a focal point 
of identifying and accessing the challenges most healthcare professionals are 
faced with in spontaneous identifying as well as reporting of falsified drugs. The 
research would ascertain Nigerian awareness and the use of the system, its 
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effectiveness, of the various technological system of identifying fake drugs such 
as (MAS, Truscan, Black Eye, RFID). 
1.2 OVERVIEW OF NIGERIA HEALTH SYSTEM 
 The World health organization report on Nigeria's health care system 
recently released ranked Nigeria overall health care system performance index 
at 187th among the 191 member states. Recently Nigeria was ranked 11th among 
22 other nations with a high rate of TB level while death by malaria accounted for 
about 300,000 deaths and 100 million confirmed cases and evidence that shows 
why the country as so much falsified malaria drug. The current health expenditure 
is about 3.6% with 0.38% of physicians per 1000 population. About 1.9 million 
people living with HIV/AIDS ranking Nigeria as the 4th largest country with people 
living with the disease as well as death from the diseases. On the 7th of October 
2019, the Center for Disease and Prevention issued a travel Health Notice for 
yellow fever outbreak which spread throughout the country with the ministry of 
health reporting cases of the disease in all 36 states. (Central Intelligence Agency 
2020) 
1.2.1Historically  
 In Nigeria, falsified medicines were first observed in 1968 when there was a 
deregulation of one of the major distributors of medicines as a result of the global 
recession that hit the world economy at that time and the consequent 
devaluation of the Naira. Thus, most drugs became very expensive and 
unaffordable for the masses leading to the issuance of import licenses for the drug 
to business individuals. Politicians always influence the implementation of such 
licenses which led to issuance to unqualified health personnel, history shows that 
Nigeria has been over-dependent on the importation of drugs from outside the 
country which led to unqualified persons bringing any form of medicinal products 
only for profit-making. This situation together with the high demand for drugs and 
limited availability of healthcare professionals as led to the availability of different 
forms of falsified drugs entering into Nigeria. (Ebenezer, 2015) 
  The country as so much huge potential for rapid growth and development, 
the countries health system still lacks good structure, and health professionals still 
find it difficult in tackling the issue of falsified drugs. History as it that the health 
sector was underfunded, corrupt, lack of government commitment towards 







 The poor economic situation in Nigeria has also encouraged the business 
of falsified drugs. The Federal Government allocated about N47bn (117m euro) 
for all its capital expenditure in 2019 in comparison to N46 billion (115million euro) 
which was proposed for the 2020 budgets showing about 2.13 percent reduction. 
Furthermore, in 2019 the Nigerian government allocated about N51.22 billion (126 
million euro) to basic health care provision funds against the N44.50 billion 
(110million euro) in 2020 which shows a reduction of about 13.12 percent 
decrease. Nigeria still faces hard times and challenges in its health sector 
including an inadequate provision and supply of health care professionals and 
poor health care facilities. Many of the country’s citizens are all living in serious 
poverty and many cannot access quality health care services because they 
cannot pay for such services. (Business, 2019). 
 In 2018 alone data from the National Agency for Food and Drug 
Administration and Control shows that the agency had to destroy fake medicinal 
products worth over N4.7 billion in four major cities such as Abuja, Shagamu, Ogun 
state, Kaduna and Gombe. This led to the agency in June of 2019 to seal about 
20 illegal drug shops and confiscate about N2million worth of falsified drugs in a 
market in Lagos. The NAFDAC Coordinator who gave an interview with the 
newsman in Maiduguri said the traders were in serious possession of banned and 
expired products. The coordinator said the raid was done after “intelligence 
gathering and undercover assessment” he reiterated that the raid was in 
accordance to measure in place to ensure major stakeholders comply with 
regulations for safety and good quality of drug for citizens. (Allafrica, 2019) 
1.3 Current Falsified drugs Directive Nigeria Vs European Union 
1.3.1 Nigeria Falsified Drug Directive  
1-Prohibition of sale of counterfeit drugs and unwholesome processed foods 
irrespective of anything to the contrary contained in any enactment or law any 
person who  
 Produces, imports manufacture sells, distributes, or in possession of. 
 Sells or displays for the purpose of re-sale  






2-Prohibition of sale, etc., of drugs or poisons in certain premises or places  
 Any persons who hawks or trades or display products for sale or conspire 
 Any drugs or poison in any place not duly licensed or registered by 
appropriate authority is guilty of an offense under this Act and shall be 
punished accordingly. 
 By appropriate authority it means any authorized body granting licenses or 
register premises for the sale and distribution of medicinal products  
3-Penalities 
 Any person who commits an offense under section 1 and 2 is liable for 
conviction and fine not exceeding N500,000 or put in the prison of not less 
than 2 years or both 
 Where a corporate body commits an offense under sections 1 and 2 shall 
be deemed guilty of the offense and may be proceeded against and 
punished accordingly. 
4-Trial of offenses 
 The Federal High Court shall be in charge of such trials. 
1.3.2 EU Falsified Drug Directives 
According to the European Union, falsified medicines are drugs that tend 
to show off as real and approved products. The EU has one of the strongest 
frameworks for licensing, manufacturing, and distribution of medicines which 
centers around the directive falsified medicine for human use, this is because only 
licensed pharmacies and authorized retailers are allowed to the resale of the 
medicinal product including any form of internet drug for resale. Thus, the 
European Union concluded that falsified medicines may contain the ingredient 
of low quality or in the wrong portions as well as deliberately and fraudulently 
mislabeled concerning their identity or source. They also include fake packaging 
with wrong active ingredients or misleading ingredients.  
In July 2011, the EU decided to add more strength and solid protection for 
individuals who are at risk of buying falsified drugs, they adopted a different 
approach to complement the directive. This directive came into full force on 21 
July 2011 while a member of states had to start applying its measures in January 
2013. It introduced a form of safety measure which was grouped in four main 
pillars. (EMA, 2018) 
1.Safety features of medicines: From the 9th of February of 2019 the marketing 
authorized holders are mandated to have two forms of safety features on the 
package of most prescribed medicinal products as well as over the counter 
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medicines. A 2-dimension barcode and an anti-tampering device. In practice the 
manufactures are meant to upload the information in the unique identifier to a 
repository called the central EU repository, wholesalers will also need to scan 
medicines at various point of the supply chain to confirm authenticity while 
pharmacies and hospitals will also scan to verify the authenticity before 
dispensing them to patients. (EMA, 2018) 
2.Distribution of products: this was introduced as part of the directives for 
wholesalers and a definition of activities called brokering as well as a new 
responsibility for brokers. 
3. Active Substances and Excipients: Effective from July 2013 all active substances 
produce outside the eurozone and imported into the zone would be followed 
through by a written confirmation from regulators of that exporting country. They 
emphasized that these statements are issued in response per manufacturing site 
and per active substance to make sure that the quality and standards of good 
manufacturing practice are always upheld. (EMA, 2018) 
4.Sales of Drug Online: The EU as made it mandatory that all online 
pharmaceutical shops must have its logo affixed on its site called an obligatory 
logo This logo will allow patients and consumers to differentiate between 
authorized online pharmacies and approved retailers. 
By far it is obvious that the Nigerian falsified directives do not address so 
much regarding the huge implication of falsified drug business. The European 
directives are much comprehensive and stronger, and Nigeria can learn from 
such a directive as it addresses different means by which fake drugs would enter 
the market. In summary, the European directive mandate shows the below(EMA, 
2018) 
1-Safety Features that would allow all applicable persons to  
 Always verify the authenticity of the medicinal product before it has been 
administered. 
 Spot out medicinal product of individual packs 
 Randomized number 
 Show evidence of tampering 
2-There is a total obligation on the repackaged product which should show 
equivalent features liability 
3-The government can make use of the system for reimbursement or 
pharmacovigilance related issues 
20 
 
4-There is a center repositories system in place which acts as a midpoint system 
for information. 
Below are some Legislations under the Nigerian medicine laws which were 
designed to assist regulate medicinal products. However, these laws have not 
been able to discourage the business of falsified drug in Nigeria(Chinwendu 2008) 
 Poisons and pharmacy Act Cap 366 of 1990: this act was formed to 
regulate the sales of compound that was termed has been toxic including 
regulating the distribution of such compound. However, this act was 
created without a clear definition of what is the term to be poisoned and 
what is not poisons 
 Food and Drug Act Cap 150 of 1990: this directive only discourage the sale 
of some foods, drugs, cosmetics as well as any form of medical devices for 
treatment of disease. It goes further to discourage the importation, 
exportation, distribution, and sale of specified drugs as well as food in a dirty 
environment. 
 Pharmacist Council of Nigeria Decree 91 of 1992: this decree requires a 
certain level of experience and knowledge about the profession before an 
individual can be qualified to be registered as a professional member of 
the council. It basically regulates the practice of profession and act as an 
investigative panel and disciplinary panel to all qualified pharmacy 
personnel. 
1.4 RESEARCH PURPOSE 
 The author main purpose is to identify the challenges the Nigerian 
healthcare professionals are facing in spontaneous identification and reporting 
of any form of falsified drugs. The author would also ascertain the level of 
awareness of health care professionals in the use of the system such as MAS, 
Truscan, Black Eye, RFID) in identifying falsified drugs and determine how effective 
they are. 
 In other to tackle these realities my study will help in analyzing the 
knowledge, attitude including experience by health professionals of the use of 
this system in identifying fake drugs. Thou the current system in place for identifying 
and reporting falsified drugs are in place yet there is little effect to the menace 
caused by the sales of this drugs to the public which always leads to adverse 
effect especially the poor citizens who can’t afford better funds to buy quality 
drugs 
 My thesis will by no means find a permanent solution to the drug problem 
in Nigeria. However, it a means of finding the next alternative solutions to making 
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sure that problems of falsified are reduced, and insight form healthcare 
professionals in fighting the menace of fake drugs sold in the streets as well as an 
open market which always leads to adverse effect in the community.  
1.5 Significance of The Study 
 Concerning falsified drug identification which is recommended by 
N.A.F.D.A.C to all hospitals in Nigeria, there is a distinctive difference in the current 
study in the practice of achieving good pharmacovigilance, when compared 
with the attitude and mentality of health care professionals in the healthcare 
industry. The majority of professionals were observed to be aware of the system in 
place to identify the fake drugs, without any doubt the need for healthcare 
personnel to be fully involved in combating these issues cannot be 
overemphasize this is because by their level of expertise there should be a high 
level of detection. The agency is determined to solve the persistent issues of a 
fake drug problem and is motivated mainly by the huge profit to be made the 
agency was then restructured with a new measure in reducing the problem 
bearing in mind that the safety of human lives remains a paramount responsibility 
for the agency in the country. 
 However, this cannot be accomplished if the healthcare professional is not 
accustomed to the system of identifying this fake drugs and while there is still a 
high rate of falsified drugs on the loose in the street of Nigeria due to the open 
market the main reasons and factors behind this issues were illustrated by a 
various perception of the healthcare professionals which needed to be 
addressed. 
1.6 Research Objectives 
 To assess the knowledge and awareness of the identification of fake drugs 
among healthcare professionals. 
 To evaluate challenges among the healthcare professionals in the fight of 
avoiding fake drugs from getting to the patient as well as reporting any 
offenders 
 To make viable counsel and suggestion on how to improve the effective 









1.7 Structure of The Study 
 The main focus of this study would be designed through the use of both 
qualitative and quantitative approaches. By quantitative approach, would 
involve the use of questionnaires and by qualitative approach, it would involve 
the use of phone calls interview. 
The questionnaires would be structured for medical doctors, pharmacists, 
and other health professionals. The first group of the questionnaire was distributed 
to the medical doctor who prescribes the drugs in the university teaching hospital 
and the second group was for pharmacists. While any other professionals 
received the questionnaire to have their opinion. 
The sections of the questionnaire were divided into 5 as follows. 
1. The demographics data and education background including experience 
of the health care professionals. 
2. The data on knowledge of falsified drug and how to detect it 
3. The data on the awareness of reporting system 
4. The possible challenges healthcare personnel are encountering in 
identifying falsified drug. 
5. The data on possible improvement on counterfeit drug identification in 
Nigeria 
Regarding the qualitative approach, a phone interview was conducted with 
experienced professionals. Though the professionals decide to remain 
anonymous in their opinion, a perspective from a medical doctor, pharmacist, 
and other healthcare professional enabled me to collect results that create a 




Null Hypothesis: All health professionals working in Nigeria have a minimum 
knowledge of guidelines and regulations for identifying fake drugs and are also 
aware of their duty to report falsified drug. They also have minimum knowledge 
of practicing good pharmacovigilance as required by regulatory agency in the 
country 
 
Alternate Hypothesis: Factors and challenges limiting good pharmacovigilance 
practice in Nigeria as well as the spontaneous identification of fake drugs in 
Nigeria due to limited knowledge of how the system works and lack of 






This chapter shows the foundation  of the study by describing the main 
context in which the research was carried out, an overview of the health system 
of Nigeria as well as the system used for identifying fake drugs, availability of poor 
medicines and weak regulations are also discussed. 
Therefore, it is very important and significant to understand the factors that 
are been faced by health care professionals in Nigeria in spontaneous identifying 
of falsified drugs to give quality and affordable drugs to the public 
 However, in other to examine the level to which the impact of the use of 
poor-quality medicines, lack of identification, and reporting of falsified drugs as 
affected Nigeria, a more systematic literature review was conducted, and 
analysis was made. Thus, a detailed and comprehensive literature review is 




















CHAPTER 2: LITERATURE REVIEW 
2.1 Introduction 
“Medicine is not a book but mind, not a business but life’’ (William Osler) 
 Located in the western part of Africa Nigeria is known to be the most 
populous country with about 215 million people, it is projected that the population 
will increase to about 392 million by the year 2050 becoming the world's fourth 
most populous country. It is divided into 6 geopolitical zones. Because of this, it is 
expected that the population rate will continue to increase in the foreseeable 
future because of the high rate of given birth. The nation's capital and sit of power 
Abuja have not been able to implement good family planning to reduce and 
space birth because of lack of political will, lack of adequate government 




Fig 3: The 6 geopolitical zones of Nigeria(Central Intelligence Agency 2020) 
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 According to the latest figure released by W.H.O, an average citizen is 
expected to live between 50 to 54.5 and this is in comparison with other countries. 
The significant factor contributing to this low level was mostly attributed to 
challenges surrounding the Nigeria Health system which as translated to the high 
rate of mortality level in the country. This is so because an estimation carried out 
shows that in every five children one out of this kid is likely to die due to the huge 
challenges the country health system is facing. (World Population Review 2020) 
 However, the Nigeria National Bureau of Statistics considers the major 
effect of the rampant AIDS epidemic in the country. While some countries like the 
United States are in control of the situation Nigeria is still struggling with its health 
system. Fortunately, the numbers have improved slightly over the last 15 to 20 
years. There are currently 3.1million residents in this country that are living with HIV/ 












2.2 Overview of the Nigerian Pharma Regulation System 
The economy of Nigerian sparked a strong enthusiasm about various 
opportunities in the pharmaceutical market, about 5 years ago the country 
noticed an outburst of the revenue that the pharmaceutical economy is 
beginning to generate yet keeping hold of this promising aspect of the economy 
has proved harder than anyone could have expected. In recent times the plunge 
in the economic system of the country as cast big hopes to the prospect of this 
sector of the economy flourishing. As Africa Biggest economy it’s been seen as 
the next frontier for the pharma sectors, however, its recent slide into one of the 
worst recessions has cast a big doubt of the regulation system surrounding the 
pharmaceutical sector. In forecast by the IMF put Nigeria GDP growth forecast to 
about 1.8% the lowest since 1987 even with such statistic there was still a strong 
belief that the pharma sector remains a strong prospect.it expected that Nigerian 
pharma market could reach 4billion dollar by 2026 if all goes well with its 
regulations (Tania et al 2017) 
 








2.3 The Pharmacists Council of Nigeria Act (1992 No 91) (the Act).  
The Act covers the major areas from drug registration, drug inspection, 





1-the regulations for 
pharmaceutical 
premises is for both 
new and renewal of 
old premises 
2-a registered 
pharmacy must be 
the owner of a 
premise used for retail 
product 
3-for a pharmacist 
business at least a 
registered pharmacist 
must be a board of 
directors and a senior 
pharmacist must be a 
direct personal 
control 
4-if the main 
objective of the 
company is in 
manufacturing the 
board of directors 
must consist of 
registered pharmacy 
which would be in 












2-it shall not be 
located in an area 
where commercial 
activities are taken 
place. 
3-if market or 
commercial activities 
is found growing near 
pharma premises 
such would be 
notified within 2 years 
to move to a new 
location 
4-where more than 
one pharmacy shop is 
found in one premise 
such shall be well 
spaced out. 
 
Registration for retail 
distribution and 
importation 
1-A formal letter in 
form of application 
letter with the 
company letter 
headed must be sent 
to the consul 
2-a duly completed 
PCNS form for 
registering the 
premises would be 
registered 
3-a photocopy of 
annual license and 
registration fees 
payable to any bank 
in Nigeria 
4-letter of resignation 
from previous 
employment if any 
5-letter of accepting 
the resignation 
6-letter of 








between the owner 





10-copy of a 
memorandum of 
association 









3-The factory Layout 
4-production layout 




6-source of water and 
Its treatment 
7- report of all analysis 
of the water 
8-report of all the 











13-copy of the letter 
showing that the 
superintendent as 
only one job 
14-letter of 
undertaking by the 
Managing director of 
the company stating 
that all affairs would 
be managed by the 
pharmacist 
15-interstate 
movement form must 
be completed 
16-Evidence of a 
pharmacist on the 
board of directors 
17-The The current 
Annual license of the 
pharmacist is also 
required. 
 
Table 1: Nigeria Pharmaceutical Regulation System (Ugochi 2020) 
 
2.3.1 The Current Situation of Falsified Drug in Nigeria 
 The current situation of Falsified drugs has exposed the weak healthcare 
system which resulted in proliferating fake drugs has led to serious treatment issues 
and sometimes the death of many citizens of Nigeria. It even became a serious 
issue when original drugs are administered to patient and  there is limited on no 
response form the drugs due to the previous intake of falsified drugs. (Akunyili, 
2006) 
 The problem of the weak policy system and so much laxity in the system, as 
well as widespread corruption, are some of the primary reasons why it so easy to 
sell medicinal products that are falsified. Producers of these fake drugs sell this 
product cheaply to the popular chemists’ shops which in turn would sell to the 
citizen. It should be noted that the main losers are the pharmacist and doctors 
who are prescribing and treating patients respectively, as the patient who is sick 
will not be cured resulting in the damage of the reputation of healthcare 
practitioners. In Nigeria, buying of quality medicines by the population is very 
important irrespective of their income level for the health care delivery system to 
succeed. This is because prices for medicines are still very high making it difficult 
for quality medicines to be accessed. Disorderly drug distribution and poor 
networking of supplied drugs as well as many unauthorized outlets as encouraged 
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the free movement of fake drugs leading to less accountability to the disposal of 
medicinal products which makes it difficult for regulations from the agency to 
work effectively. (Chinwendu 2008) 
 Due to a major decline in the quality of Nigeria's health structure and infant 
rate increasing day by day, keeping up with effective identification as well as 
reporting of these falsified drugs remains a serious burden and challenges that 
are yet to be solved. Insufficient healthcare professionals as reduced any form of 
good pharmacovigilance practices in Nigeria and as a result combating the 
effect of falsified drugs remains unresolved. Also, in Nigeria, the unfavorable 
working conditions and ignorance among healthcare professionals in the use of 
the system for identifying and reporting medicinal products that are falsified as 
reduced all efforts that are been channeled towards achieving laid down rules 
of good pharmacovigilance practice. Hence there is a need to upgrade the way 
by which the Nigerian system operates concerning good pharmacovigilance 
practice. Therefore, involving healthcare professionals is necessary since they are 
the frontline staff that either prescribe or dispense this drug. 
 It was observed that the huge increase in Nigeria falsified drugs incidence 
was also attributed to the haphazard regulations surrounding the license issued 
to those who are involved in the drug business was just issued by the politician in 
the ’90s without any form of due diligence without taking into consideration the 
citizens health and the implications of their actions. As a result of this action, all of 
the beneficiaries of the import license discovered that so much money would be 
made from the drug business leading to the high emergency of drug importers. 
The market became very competitive and for competitors to stay above the 
other a fast way needs to be created to ensure that products are made 
available, some looked at importing fake drugs and medicinal products to have2 
an edge over other competitors. In Nigeria today, drugs are still treated as general 
merchandise that is sold in the open market including moving cars, faceless 
medicines stores, boats, ships, and even in stores where provisions are being sold. 
This translates to the fact that the distribution network was handled by 
professionals who are only interested in profit-making at the expense of public 
health. (Nigeria bulletin 2019) 
 Another current issue occurred recently in March 2020 where 32 illegal 
pharmacies and famous chemist stores were shut down due to the illegal offenses 
surrounding the operations of the stores. The commissioner for health professor 
Akin Abayomi who made this known on Sunday after a review of the enforcement 
exercise carried out by the pharmaceutical inspectorate unit of the ministry for 
2020 said that “the affected premises include 6 major areas in the local 
government area of the state”. (Akin 2020) 
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A review shows that counterfeiting and substandard forms of anti-malaria 
drugs and antibiotics have shown in the table below are most common in Nigeria 
and does not generally mean that other forms of falsified drugs do not exist. There 
is a greater probability that other forms of drugs have not been tested or sampled 
for testing(Theodore 2007) 
DRUG CLASS EXAMPLES 
ANTIMALARIALS  Artemisinin derivatives: dihydroartemisinin and 
artemether-lumefantrine 
Others: Chloroquine, Sulfadoxine-pyrimethamine, 
Quinine sulfate and Halofantrine 
Antibiotics Penicillin: Ampicillin, Ampicillin-clavulanate, Ampicillin 
cloxacillin, Amoxicillin, Cloxacillin) 
Macrolides: Erythromycin 
Sulphonamides (Cotrimoxazole, Sulphamethizole), 
Quinolones (Ciprofloxacin)  
Aminoglycosides: Gentamycin and Neomycin 
Other: Chloramphenicol, Tetracycline, Metronidazole 
Table 2: Showing different forms of Falsified medicines(Theodore 2007)  
2.3.2 W.H. O IMPACT ON FALSIFIED DRUG IN NIGERIA 
In late 2006 WHO lunch a task force to help countries especially Nigeria fight 
the multimillion thriving dollar illegal trade in falsified drugs known as International 
Medical Products Anticounterfeiting Taskforces (IMPACT). Its major aim was to 
create a form of communication with Nigeria on how to put an end to the trade 
of fake drugs and studies. Dr. Howard said in his statement “We need to help 
people become more aware and also create a communication line that would 
help improve the situation of the falsified drug in Nigeria”. The task force would 
ensure good public distribution of medicinal products, pharmacists, and hospital 
staff to inform the authorities about any form of suspicions about the originality of 
any form of the medicinal product. The agency noted that any reporters would 
be followed up through so that people who report about falsified drugs would be 
motivated to report again in the future. (World Health Organization 2020)  
 Enforcement officers in Nigeria would love to enforce fake drug 
identification on the spot but what the agency as noted is that due to the high 
level of corruption in the country it's very difficult for them to respect the agency.  
Reggi in is a statement said, “We could make packaging device that is resistant 
to forgery by using security features found in banknotes, but the problem is that 
our policy is sometimes not well respected enough”. 
 Although it's very difficult to get a precise figure because falsified drugs are 
found almost everywhere in Africa and Nigeria is one of the main markets of such 
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business. In Nigeria, drugs are sold through the open market alongside food, fruits, 
and vegetables though people may be aware of the risk the fact is there is no 
other place to get cheap drugs. Reggi knows that the challenges are huge in 
Africa especially Nigeria, but he stressed that the agency is working with 
government agencies to create a database of products by which each 
medicinal product will have its unique number that would be tracked effectively. 
This they believe would greatly improve the situation as a product can be check 
to ascertain if the medicine is genuine at the point of distribution into the pipeline. 
(World Health Organization 2020) 
2.4: Overview of Pharmacovigilance in Nigeria 
 Nigeria joined the W.H.O international Drug Program in 2004 which started 
a new era of pharmacovigilance in Nigeria. As the west African country, the 
presence of different forms of disease burden and medication use becomes 
significant. As a result of this, there is more pressure increase on safe medicine 
practices by the government and healthcare professionals concerning the 
patient.  The NPC is tasked with the duty of liaising with other international groups 
such as W.H.O, US Food and Drug Administration, and the European Medicines 
Agency in ensuring drug safety good quality drugs in Nigeria. (Olowofela et al., 
2015) 
 The National Pharmacovigilance Centre (NPC) defines pharmacovigilance 
as “the science and activities which is focused at the detection, assessment, 
understanding as well as prevention of adverse effect and any form of drug-
related problem cause by either substandard, falsifying, and expired drugs. In 
other parts of the world problem related to pharmacovigilance are issues like 
medication error, lack of efficacy reports, bad labeling of medicinal drugs, 
poisoning from drugs, and drug misuses. However, with all these issues listed 
Nigeria is not exempted as I provide an overview of pharmacovigilance in Nigeria 
about falsified drug reporting. (Olowofela et al., 2015) NAFDAC act CAP N1 LFN 
of 2004 as amended gave full legal backing into the activities which were carried 
out by the NPC to date. Also, a national policy on drug issued in 1990 and revised 
in 2005 shows the level of drug safety, the Nigerian national Pharmacovigilance 
policy, and the implementation framework serves as the policy document that 





Fig 6: Nigeria Pharmacovigilance operations 
A current study was carried out aimed at evaluating the attitude and 
practice of good pharmacovigilance practice regarding falsified drug the study 
involving medical doctors working at a well-known teaching hospital. A total of 
100 doctors responded to the questionnaires, it was discovered that only 57.1% 
considered to check if drugs are falsified before prescribing, all of whom were 
aware of the procedure of reporting this offender. While the awareness of the 
existence of the National Pharmacovigilance Centre (NPC) was 51.4%. 30% have 
encountered adverse drug reactions due to fake drugs but only 2.9% have ever 
reported it. Most of the respondent 60% never considered falsified drug reporting 
system as an important  tool in pharmacovigilance in the prevention of falsified 
drug-related issues(Adedeji et al., 2013) 
2.5 Pharmacovigilance and Falsified drug identification 
 Pharmacovigilance (PV) in Nigeria is usually viewed and assumed that drug 
quality and its efficacy are always assured and as result, there is no need for safety 
monitoring regarding the quality of the drugs that is been provided to the patient. 
For many countries around the world where the business of counterfeit drugs has 
been reported, it became an obvious fact that it is no longer safe to make this 
assumption while monitoring and authenticity of medicinal products. 
 Pharmacovigilance must, therefore, be on the frontline and alert to any 
form of Falsified drugs because with counterfeits, a country may not just be 
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dealing with the medicine one assumes to be monitored. And hence there is a 
great call that pharmacovigilance scope should be upgraded beyond signal 
detection to other safety concerns and falsified medicines constitute one of those 
yet to be integrated safety issues. (Akunyili 2016) 
 A previous study was carried out to examine the level of 
pharmacovigilance program (PP) among different forms of health professionals 
in Nigeria. The study was designed to compare personal factors that were 
concerning the awareness of PP among the general public. The study made use 
of data that was collected through the country's HIV and AIDS survey which was 
collected through a group of the survey of women aged between 25-35 years 
and men aged between 25-45 years across all geographical areas of the country. 
It was noticed that the average age of the respondents was between 28.5 while 
the respondents were majorly made up of females of about 49.1% with 68.7% 
residing in the rural areas. Results show that out of the percentage of people that 
responded 26.6% was well aware of the PP and this was much higher with those 
people with higher education (55.5%) while those who have heard about 
campaign on adverse drug reaction were 80%. respondents who have to listen 
or had the opportunity to hear about this campaign in the urban city was more 
likely to have higher awareness level in Nigeria while those with a lower level of 
education background especially in the rural areas are significantly 
low.(Oluwafemi et al., 2017) 
 The writer designed this study to assess likely factors affecting the level of 
awareness of the Nigerian Pharmacovigilance program through data fro HIV 
survey in 2012. He found out that the awareness level generally low and not much 
importance as been placed in this area of the health system to upgrade the 
sector. He further states that except for some little media advert in the urban city 
which was evident as to the reason why respondents in the urban areas as better 
awareness level, proper education system on the topic of adverse drug reaction 
in the education system of the country have not been fully incorporated. The 
writer believes that educating the profession about pharmacovigilance would 
have a good positive impact on the level of awareness across all individuals in 
the country.(Oluwafemi et al., 2017) 
 Results show that 49.1% of the total sample with 68.7% living in the rural areas 
are not aware while 19.6% was aware of the program in Nigeria. The ratio of men 
to female reporting awareness of the program was significantly higher when 
compared to the female respondents 38.8% to 33.1% respectively while the ratio 
of those who reported awareness of Pharmacovigilance program and those who 
have not heard about any campaign are 80.5% to 10.5% respectively in the urban 




The author concluded that the awareness is generally low in rural areas due 
to insufficient NAFDAC campaign. This is because there was a greater 
percentage of the respondent in urban areas who had better access to listen to 
the campaign to be significantly aware of the program in comparison to the 
respondent who is found in the rural settings. Thus Arenes of PP could be 
enhanced through a more robust campaign that should cut across all levels of 
geographical areas of the country, they should implement a low level of advert 
such as jingles and handbills as this would intensify further awareness in the rural 
areas.(Oluwafemi et al., 2017) 
Therefore the writer concluded that to detect falsified drugs Nigeria needs 
to upgrade its pharmacovigilance systems and not just focusing more on 
monitoring alone, to tackle this problem of falsified drugs national PV data needs 
to be feed into a global reporting system that can give a more actionable 
knowledge and intelligence to healthcare professionals and public health care 
policymakers. There is currently no form of a reporting system for the suspected 
case of falsified drugs which should be part of the database of the 
pharmacovigilance center.(Oluwafemi et al., 2017) 
2.6 Awareness of Healthcare Professionals in Identifying Fake drugs 
Concerning the country’s healthcare professionals in identifying fake drugs, 
a survey was carried out to assess the awareness of the Mobile Authentication 
Service (MAS) over another system of identifying fake drugs in Nigeria by health 
care professionals in Nigeria such as Radiofrequency identification system, Black 
Eye, Truscan. A  survey was used to evaluate health care professionals especially 
the pharmacist on their acceptance of the technology, it started with a 
questionnaire distributed to 326 community health care professional followed by 
an interview guide to explore any form of challenges faced in using the 
technology in Nigeria. 
Results show that only about half of the healthcare professionals are aware 
of the system in place in identifying the fake drug and prefer the MAS system over 
every other technology system, about 40% of respondents are generally aware of 
this system while 60% are not aware. Furthermore 51% of a health care professional 
would recommend the use of these technologies to other practitioners while 54% 
of the respondent would encourage their clients to use it. The study shows that 
both awareness and perceived reliability are a major factor that plays an 
important role in the use of the systems. The finding further shows that the 
challenges were due to global system downtime, low power supply, the limited 
ability of consumers to use short message service all contributed to the limited 
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advantage that the system could have provided. Therefore, the study concluded 
that the level of awareness is moderate in comparison to the level of counterfeit 
drugs in the country. (Oyetunde et al., 2019) 
Health care professionals (medical doctor, pharmacist) are professionals 
that usually have contact with people who are very ill at the most vulnerable time, 
therefore they bring awesome influence on the health and wellbeing of the 
patient. it should all start by health care professionals been fully aware of the issue 
combating counterfeit drugs starting by the use of the system at all times, this is 
because if healthcare professionals resolve to proactively play their part early 
enough in eliminating counterfeit drugs from their practice, a substantial 
achievement would be achieved. What it simply means that a self-regulatory 
measure that promotes rational use of the system they are accustomed to, 
uphold ethical practice, enhance professional practice and work for a common 
goal for the safety of the patient.  
To win the war of falsified drugs, as the nation strives towards a healthy 
population the health care professionals should be fully aware and take 
responsibility for ensuring that no falsified drugs pass through them. This is because 
medical doctors and pharmacists are crucial professions in stopping these drugs 
from reaching the patients (Akunyili, 2007).   
2.7 Challenges Among Healthcare Professionals in Identifying Fake Drugs. 
 Basically, in Nigeria, almost everything that comes into the country is either 
falsified or substandard starting from fake motor spare parts, to fake chemicals, 
and adulterated food items and falsified medicinal products. In reality, it appears 
that Nigeria is a dumping ground for any form of the falsified product. Over the 
years Nigeria's health system has been suffering from the period of so much 
forgery of products, counterfeit drugs, quack health professionals, street drug 
trading, quack chemist shops, and quack hospitals. An experimental suggestion 
has shown that there may be a more falsified drug in circulation than genuine 
and original drugs in circulation. What is more disturbing is the concept of falsified 
drug issues is that the effect of consuming such a form of medicinal products 
usually goes unnoticed most of the time except in most cases where it results in 
mass deaths. There is generally no factual data that shows the mortality and 
morbidity which is a result of consuming falsified drugs in Nigeria because of the 
level at which the pharmacovigilance practices are carried on in the country. 
One of the most tragic cases that shock the nations occurred in 1990 when 109 




 This alerted the pharmacy society of Nigeria to pressurize the government 
to take a bold step towards regulating and controlling the menace of the falsified 
drug business in Nigeria. The government stepped in and created the counterfeit 
and fake drugs (miscellaneous provisions) decree No.21 of 1998. This decree was 
in place to discourage any form of sale and distribution of falsified drugs or poisons 
in open markets and without any form of a license of registration. It also added 
penalties and fines for any breach of the provisions of the decree, a special task 
force was then established to enforce these regulations and ensure compliance. 
(Babalola et al., 2013) 
 Given the issues affecting health care professionals, a study was carried on 
accessing the challenges of health care professionals in identifying falsified drugs. 
A survey was carried on by health care professionals working in a different 
regulatory agency, amongst the regulatory agency were (i) Federal task force on 
counterfeit and fake drugs (ii) The National Agency for Food and Drug 
Administration (III) The Pharmacists council Of Nigeria (IV) The Pharmaceutical 
Society of Nigeria, (V) Nigeria Association of General Practice Pharmacists, (VI) 
the Pharmaceutical Manufacturers Association of Nigeria. It was also observed 
that all these bodies have at the list in the past conducted seminars and reviews 
in the last two years on the issues of fake drugs, thus they have consensus 
agreement towards the topic. There was a 100% response rate from all seven 
organization who responded unanimously that the issues of falsified drugs in 
Nigeria was a major concern and it is killing the Nigerian health system. 
 The table below shows the challenges given by the different organizations 
for the continuous increase of falsified drugs in Nigeria. 
Reasons # of Respondents 
(N=7) 
Laws are inadequate  6 
Ineffective enforcement of existing 
laws 
7 
Non-Health Professionals in Drug 
Business 
6 
Loose control systems 2 








1- Ineffective Enforcement of Existing laws: All respondents (100%) agreed that the 
laws were not just properly enforced and its most common in developing 
countries. For instance, strict regulations have been placed in Bangladesh as a 
way of controlling numerous small and illegal pharmaceutical production of 
falsified drugs. Some of the respondents (60%) believed that fines in place were 
just too small to penalize offenders, for instance, N5000 fine or two years 
imprisonment. Healthcare professionals believed that fines should be increased 
to a more aggressive amount with more years in prison to scare and discourage 
their activities. (Babalola et al., 2013) 
2-Nonprofessionals in Drug Business: Another 88% of the respondents in this study 
indicated that too many non-health care professionals in the drug business are a 
major challenge the professionals are facing leading to more falsified drugs in the 
market. In Nigeria pharmacist is authorized by law to produce, sell, distribute, 
import, export dispense medicinal products. Also, pharmacists which have 
registered shop in a premise can sell drugs in the community, however, some non-
professionals can be authorized to sell patent medicines who are referred to as 
patent medicine vendors. They are generally involved in the sale of drugs like 
antibiotics, narcotics, and toxoids. Hence it was observed that such non-
professionals do not know how to identify counterfeit and fake drugs. (Erhun et 
al., 2013) 
3- lose control Systems: the majority of the respondent (85.7%) indicated that 
inadequate funding of the health system is a major cause of the system being out 
of control. One of the major functions of NAFDAC is to regulate and import 
medicinal products which are usually done by having inspectors at various land 
and seaports. As part of the decongestion process by the Nigerian ports authority, 
the agency together with Standard Organization of Nigeria (SON) was asked to 
move there operations in other to free up space from the seaports, this move was 
heavily criticized as this would encourage more influx of fake medicinal products 
into the country. one of the major criteria for sales of drugs in Nigeria is for it to be 
registered and most of the laboratory available are not well equipped for the 
volume of quality checks that need to be done, sometimes drugs are returned 
stating reasons of inadequate equipment and lack of logistics for proper 
inspection. (Erhun et al., 2013) 
4- High Cost of Drugs: About 71% of the respondent also indicated that the cost 
of drugs was a major concern, this was because the cost of genuine drugs are 
very expensive attributing to the fact that local inputs of drug production are 
relatively small. (Erhun et al., 2013) A study was also carried out in 6 local 
government areas in Lagos state Nigeria to check that the cost of good quality 
drugs, its specification concerning international guidelines and level of API, and 
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impurity specification. Out of the 200 drug samples that were collected 30 of 
these drugs (29.3%) were falsely labeled, 76 (74.5%) were substandard, 78(76.5%) 
were poor quality and 24 (23.5%) were of good quality. It was discovered that of 
all 76 drugs that were declared substandard 28 were also labeled falsely, 
17(56.7%) was found in an area of low-income earners, and 40 (52.6%) of the 
substandard medicinal drug products came from areas with high-income 
earners. Prices between these classes were compared, the average drug price 
for falsely labeled drugs was 383.33 NGN concerning 955.50 NGN concerning 
good quality drugs. This was evidence of why the prevalence of falsely labeled 
and substandard drug samples was high in Lagos. (Ndichu et al., 2019) 
5- High Level of Corruption: about 57% of the respondent indicated that 
corruption was also a major challenge the health care professionals are facing in 
a bid to fight the menace of falsified drugs, it was evident that the magnitude of 
the corruption in this sector lead the Nigerian Assembly to establish the anti-
corruption law enforcement agents 43% of the respondent attributed that greed 
in a bid to enrich one’s pocket has also contributed to the prevalence of fake 
drugs all over in Nigeria it's hard to fight a corrupt system. “Get rich quick 
syndrome/value system that encourages all forms of corrupt practices 
enrichment. There are does who believes that the end justifies the means, in most 
case business owners agrees with some foreigners to import substandard product. 
(Erhun et al., 2013) 
6- Ignorance: in total, about 100% of respondents all agreed that ignorance 
among health care professionals played a factor in the challenges of the drug 
available in the country. About 70% of the respondent attributed to a low level of 
literacy between citizens and health care professionals. The belief is that some 
health care might not even be aware of how to identify fake drugs even with the 
technology in place or they are aware of it and will not put them into practice. 
The falsified drug business has become sophisticated over the last decades and 
new and improved method are always in place to ensure they are not 
caught(Erhun et al., 2013) 
 The European countries are also not left out from the challenges of falsified 
medication with the establishment of European Falsified Medicines Directives, the 
challenges of falsified medicines in Europe are also on the increase at a dramatic 
rate. A 2010 survey was conducted by Pfizer in 14 major European countries to 
ascertain challenges still faced by health care professionals in identifying falsified 
drugs. It was observed that more than 10.5 billion euros was spent each year on 
falsified drugs and many of this drug was for weight loss, influenzas, and erectile 
dysfunction, and which are majorly counterfeit. One of the major challenges the 
European market is facing is the illegal online pharmacies and about 14,000 illegal 
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websites that sales falsified drugs were shut down. A survey was done on 530,000 
medicinal products which were inspected by customs and regulatory authorities 
worldwide, out of these products 42,000 packages containing antibiotics, cancer 
medication, and antidepressants and dietary supplements where falsified. 
Worldwide sales of counterfeit drugs are over 75 billion dollars according to W.H.O 
about 1% of counterfeit drugs have penetrated the supply chain while 10% of all 
pharmaceuticals distributed around the world are falsified. (Peak-ryzex 2020) 
 
 
Fig 7: Word wide distribution of a falsified drug 
 
2.8 Recommendation for Improvement of Falsified drug identification 
 On 25th January 2019, a study was carried out to evaluate the awareness 
of healthcare professionals towards the improvement of good 
pharmacovigilance practice in Nigeria. The author randomly selected six different 
teaching hospitals in the south-south zone of Nigeria, located in the coastal region 
of Nigeria and home to about 21 million citizens. This zone comprises six states 
Akwa-Ibom, Bayelsa, Cross-Rivers, Delta State he included an educational 
seminar by sending a text message every month through a short message service 
over a 12months periods followed by a  questionnaire which was filled 
anonymously by health care professionals including the doctors, pharmacists, 
and nurses in regards to knowledge awareness of pharmacovigilance in Nigeria. 
A repeated cross-sectional study was then carried between January 2016 to April 
2017, the design was selected because of the high probability of loss in follow up, 
resident doctor existing from the program and assign of other staff health care 
workers to other station. 
 A total of 40 questions was distributed in which 10 questions were in relations 
to health care professionals attitude, 18 focused only on reporting practices, 
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some other information’s such as age, years of experience in the profession, sex, 
institution, knowledge of falsified drugs, reporting system, a regulatory agent of 
pharmacovigilance, perceptions and other practices in identifying fake drugs. 
 Results show an approximate number of post-registration Health care 
professionals working in the selected teaching hospitals who are eligible for 
inclusion in the study with over 2085 doctors (42.4%), 2662 nurses (54.2%), and 165 
pharmacists (3.4%). A total number of 3099 HCPs in the intervention arm and 1813 
in the control arm. However, only one-third of the HCPs in the intervention arm 
participated in the intervention invitation sent out. Also, a total of 811 HCPS (65% 
intervention and 35%) participated in the preintervention study (response rate of 
70.8%) and 931 HCPS in the repeated cross-sectional study having a response rate 
of 77.6% (64% intervention and 36% control).   
The writer shows there was a significant increase in knowledge across 
several items between the groups. The professionals from the intervention group 
were better educated and informed with improved knowledge on how to identify 
falsified drug, analysis shows that from the post and pre-intervention questionnaire 
there where little knowledge across several groups, the HCPs from the intervention 
group had a better understanding and knowledge of identifying fake drugs as 
well as attributes of fake drugs. Also, data shows that there was a significant 
increase in awareness among the southern zonal pharmacovigilance center 
concerning the control group. Furthermore, the survey shows that those 
respondents in the control arm prefer the pharmacist to identify and report 
falsified drugs even with the strong belief that all categories of healthcare 
professionals should be able to identify fake drugs. In conclusion, the writer 
showed improvement in the knowledge and practices including an efficient 
process of the reporting system will further assist professionals. (Opadeyi et al., 
2019) 
 Another significant research was carried out in 2015 to access the attitude 
of healthcare professionals towards pharmacovigilance practice and falsified 
drug identification in Saudi Arabia. The study was aimed at investigating the 
knowledge and awareness of HCPs in governmental and private hospital settings. 
A survey among pharmacists, physicians, and nurses in 12 hospitals was 
conducted between November and December 2015. The survey consists of 18 
questions assessing the knowledge awareness and attitude of HCPS towards the 
technology and science involved in identifying fake drugs as well as good 
pharmacovigilance practice. The data collected was then analyzed using 
Statistical Analysis Software (SAS 9.3). thus, the main outcome measures 
Knowledge, attitude, and practice of HCPS towards 
pharmacovigilance(Alshammari et al., 2015) 
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 332 healthcare professionals completed the survey with a response rate of 
72%, 110 (34%) physicians, 106 (33%) pharmacists, and 104 (32%) nurses more than 
half of the respondents have no idea of correct ways of identifying fake drugs. 
Two-Thirds of the participants 207 (65.5%) did not know the aim of post-marketing 
surveillance yet only 113 (36.9%) of the participants were of the 
pharmacovigilance drug safety center adding to this most of the respondent 
(78.4%) believed that reporting was professional obligations and hospitals should 
have a department for this. The writer then concludes that limited knowledge of 
pharmacovigilance would have affected reporting incidence. Thus, intervening 
through the education program and training need to be applied by the drug 
regulatory authority to enhance pharmacovigilance and drug safety. 
(Alshammari et al., 2015) 
 The problem of falsified drug identification is real and constitutes a major 
threat to the Nigerian population and the system needs so much improvement. 
A descriptive study was carried to assess the improvement of identification of 
counterfeit Drugs by the community in Lagos state, the research involves the use 
of 23 items of the questionnaire which was administered to consenting community 
pharmacists in 17 out of 20 Local Government Areas in Lagos State. A simple 
sample of health care professionals in the community who deals with medicinal 
drugs was recruited for this purpose this was gotten from the Association of 
Community Pharmacists in Lagos state. An effort was made to ensure adequate 
representation of Pharmacies in every local government area in Lagos state, data 
were collected for this study form 17 out of 20 Local government areas in Lagos 
state sample was chosen to show the allocation of community health care 
professionals registered in Lagos state. The writer had two sections to the 
questionnaire. Section A was designed to elicit demographic information of the 
respondents such as age, location, profession while section B was made up of 17 
questions with a Yes or No answer and some questions was focused to determine 
the method employed by the respondents to detect fake drugs, factors that 
determines where they source their drugs, frequency of any form of the falsified 
drug. (Odili et al 2016) 
 A total of 100 copies of the questionnaire were distributed to the 
community 69 out of the 100 copies were responded to hence receiving a 
response rate of 69%. About two-thirds of the respondents 65.2% (45/69) were 
males and an age grade of 31-50 years made up about 73.3%. All respondents 
agreed that Nigeria's health system is flooded with falsified drugs and counterfeit 
drugs, 74% of the respondents describe the problem as a major, the remaining 
26% as moderate. Some 86% of the respondents procured their drug products 
personally while 14.5 were not personally involved in drug procurement. 75% of 
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respondents sourced their drugs from middlemen and drug wholesalers while 
others source from the open market, 
In the relation of detecting falsified drugs, 83% of the respondents agreed 
that they check for the originality of their drugs through the NAFDAC registration 
number. 80 percent believed that the job of identifying fake drugs is for the 
pharmacist. About 60% of respondents had experience in identifying falsified 
drugs through the use of NAFDAC technologies after receiving some form of 
training while no respondents reported ever receiving any help from regulatory 
officials in detecting fake and falsified drugs. 60% of respondents had reported 
the case of fake drugs to the regulatory authority. The writer then concluded that 
more awareness is needed to be made to expose healthcare professionals to the 
use of the system and this should be made compulsory, however evidence shows 
that HCPS that are trained have a better understanding, most health care 
professionals still lack the knowledge and personal attitude in using the 
technologies. There should be monthly training to further boost healthcare 
professionals in the use of the system. (Odili et al 2016) 
 This section discusses the various methods participants perceived that the 
agency should use in making sure the identification of falsified drugs using the 
technology systems is a success. This included suggestions from participants on 
actions that could be taken to help improve the system, respondents were then 
asked how they thought falsified drug can be identified spontaneously using the 
system available and one of the points raised through the interviews was to 
improve the general awareness of the system. 
2.9 Improved Awareness Creation 
Respondents suggested the need to raise awareness as the best ways of making 
sure this technology is in use and become more efficient. A major way that was 
thought of as a more efficient way of creating awareness about the technology 
is through creative awareness by advertising in different languages since Nigeria 
is multi-lingual culture. (Ebenezer, 2015) 
“Well like I said they just need creative awareness. There is an urgent need to carry 
everybody along. This involves been creative on-air, place awareness in different 
languages teaching health care professionals how to use the system, do it in a 
different dialect, different languages so that people would understand the value 
of this system” 




Some health care professionals believe that different means of awareness needs 
to be created to make it easy to identify fake drugs instantly and send reports. 
Aside the use of conventional means of adverts such as through the television, 
radio, and newspapers another interesting point raised was to find a way of 
reaching health care workers such as talking to them during health seminar 
workshops or gathering as stated below(Ebenezer, 2015) 
“if awareness is really low then they should take the awareness to all forms of 
health workers seminars and workshops talking to people about the technology’’ 
      Pharmacist 5 male 
Assistance by government and their agencies 
Some people were of the view that the government and all available agencies 
play a vital role in the introduction and expansion of the systems. The respondent 
was of the opinion that government can by taking charge of the cost of using the 
systems which is currently been funded by health care professionals. This would 
go a long way in assisting the professionals since they don’t bear the burden of 
purchasing the equipment. (Ebenezer, 2015) 
“I tell you ones the government assist in helping the professionals to purchase this 
system they would be encouraged to use the system.” 
       Community pharmacist 1 female 
“in Nigeria to put up an advert on the news is so much. Half a million for a one-
minute advert that’s how much is been charged for a 2 minutes awareness. Who 
would love to spend a lot of money on a particular product? So, the government 
should intervene to help companies with a kind of discount to assist companies 
who produce original drugs at cheaper rates” 










Choice of medicines that will be Technology enabled 
 For some reason, there was some disjointed agreement among 
respondents as to which medication should be made compulsory for the use of 
all forms of NAFDAC technology to test the quality drugs hence they suggested 
that it should be on drugs that are of high demand. However, except for the 
consumer, all stakeholders were of the single idea that using of this technology 
should be focused on medicines that are likely to be falsified using the technology 
on all forms of medicinal product (Ebenezer, 2015) 
“well, I don’t think that every medicinal product would like to copy or counterfeit. 
They are looking for those medicinal products that are of high demand whose 
products are moving very fast and very expensive. For me, that was what is 
important” 
        Community pharmacist 7 male 
“For an economic reason, I don’t think every medicinal drug should be waiting 
for the test, you why companies are doing everything possible to protect their 
products. If a product is not at risk of being fake, then there is no need”. 
        Policy marker 2 male 
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Authors Year of Publication Sample Size Key Points from 
Article 
Conclusion from Article 
Adedeji et al Evaluation of the 
attitude and practice of 
good 
pharmacovigilance 
practice in Nigeria 
teaching hospital l2013 
100questionnaires 
response rate of 93.3% 
57.1% considered to 
check if drugs are 
falsified 
51.4% are aware of 





reaction due to 
falsified drug 
2.9% have reported 
60% consider the 
reporting system 
ineffective 
Increase awareness of 
the technology involved 







in Nigeria 2017 
68.7% response rate in 
rural areas 
98% response rate in 
urban areas 
49.1% are aware of 
campaigns by the 
government on 
pharmacovigilance 
program in rural 
areas 
19.6% are not 
aware of the 
program in rural 
areas 
80.5 are aware of 
the program in 
urban areas. 
10.5% are mot 




system in Nigeria should 
be upgraded to involve 
tackling of falsified drugs 
and also create more 
awareness at all areas of 
the country with the use 
of jingles and handbill. 
Oyetunde et al Awareness of MAS over 
other systems such as 
RFID, Black Eye, Truscan 
326 questionnaires 
were distributed  
40% of respondent 
are generally 
aware of the system 
60% are not aware 
of the system 
51% recommended 
the use of the 
system  
The level of awareness is 
relatively low in 
comparison to the level 
of the falsified drug. 
Health care 
professionals should be 
fully aware of this system 
and put it in use. 
They should be 
proactive at all times 
Babalola et al  Accessing the 
challenges of health 
care professionals in 
identifying fake drugs 
7 regulatory agencies 
took part in the survey 
85.7% believes the 
law is available  
100% believes laws 
are not enforced 
60% believe fines 
and penalties are 
small 
The writer concluded 




professionals, high cost 
of original drugs as well 












to lose control 
system 
71% of respondents 




100% of respondent 
believes ignorance 
is a key challenge 
corruption are the main 
challenges facing the 
health care professionals 
Opadeyi et al Educational Intervention 
to improve the 
knowledge, attitude, 




811 health care 
respondents in Pre-
intervention study and 
931 healthcare 
respondents in the 
post-intervention 
study 






on how to identify 
falsified drug, 
Proper training and 
organizing seminars 
would lead to and an 
improved knowledge 
Odili et al A descriptive study to 
assess the improvement 
of identification of 
counterfeit drugs 2016 
100 copies of the 
questionnaire  
69% response rate 
69% respondent 
agreed that Nigeria 
system is flooded 
with fake drugs 
74% describe the 
problem as major 
26% describe the 
problem as 
moderate 
83% check for 









81% have never 
reported  
More awareness is still 
needed in other to 
improve the system. 
Improved knowledge on 
the use of the system is 
key to identifying fake 
drugs 
More training should be 





After delicate research and study of different literature review on research 
papers, articles, journals from Nigeria and  all around the world, it is obvious from 
the evidence gathered that the challenges surrounding falsified drug 
identification as continue to significantly become a serious issue despite sustained 
increase and efforts made towards pharmacovigilance practice in Nigeria by 
regulatory agency in Nigeria to combat these crises including educating 
healthcare professionals. Major findings from the literature review showed a low 
level of knowledge and poor attitude as the main factor responsible for 
healthcare professionals lack the spontaneous identifying fake medicinal drugs 
through the use of the system. 
 The majority of the respondents believed that the presence of falsified 
drugs is still a problem in Nigeria even with certain measures introduce to 
spontaneously identify the fake drugs. Some of the challenges that were 
identified were the high cost of original drugs, poverty, corruption, high level of 
corruption, inadequate laws and poor enforcement, ignorance among health 
care professionals, and the presence of non-health care professionals in the 
business.  
 The chapter presented the findings from the second phase of my research 
which also involved a semi-structured interview. Extensive samples of quotations 
from the different respondent were also used to build the confidence of the 
readers that the view presented accurately represent the reality of the persons 













CHAPTER 3: RESEARCH METHODOLOGY 
3.1 Overview  
SECTION NO PRIMARY DATA PART A PART B 
1 Approach Quantitative analysis Qualitative analysis 
2 Philosophy Positivism Interpretivism 
3 Source Questionnaire: 




4 Structure 6 sections made up 
of 33 questions 
5- 15 mins phone 
interview 







Table 4: Methodology and Data Collection 
3.2 Research Approach 
In other to determine the challenges and factors that as limited the 
healthcare professionals for identifying falsified drugs in Nigeria, the author made 
use of two methods, by using both questionnaire-based surveys and interviews 
through phone calls which was centered on medical doctors, pharmacist and 
other health professionals. 
The author started by creating a survey (quantitative method) through the 
use of Microsoft forms and distributed online, this consisted of a core part of the 
research and they were requested to answer and fill the questions online. This 
enables the author to gather as much needed information and data used for 
analysis. Most of the questionnaire was outlined to show the general view towards 
identifying falsified drugs and check for the awareness of the professionals to the 
various famous of the system used in identifying fake drugs. Thus, this perception 
enabled the author to pinpoint how best to deal with these sets of health care 
professionals and give a possible recommendation. 
Furthermore, a phone interview (qualitative method) was conducted to 
get the personal perspective, attitude of highly experienced health professionals 
towards falsified drug identification and also current pharmacovigilance practice 
in Nigeria, challenging factors that still encourage the business of falsified drug in 
Nigeria, awareness and possible recommendation that is sustainable for the 
system. The Data collected from both sets of health professionals would be 
compared to other literature findings to enable the author to give a concluding 




3.3 Research Philosophy 
The research philosophy in line with the research work was well thought to 
be that of positivism and interpretivism. It was meant to explain all responses from 
the questionnaire which would assist the author is giving a well-balanced 
conclusion to the study conducted. The inference of this research was solely 
depending on different forms of observation that are quantifiable which helped 
in the analysis of the data gathered. Thus, the research would advance from 
been an hypothesis as the notion being studied was easily quantifiable and need 
a large amount of randomly selected professionals. 
 The health professionals were provided with a structured questionnaire in 
which data was collected, analyzed, and interpreted very objectively. The author 
only used the facts that were available to him at this point irrespective of different 
constraints that disrupted the data in the global crises of coronavirus. This was 
then enforced by the use of electronic survey options to avoid any form of 
unnecessary interaction with the respondents and encourage anonymous 
response so that professionals can fully express their answers in the survey without 
any biased mind. 
 By interpretivism approach information was obtained through a carefully 
selected phone interview method which then resulted in the main data that was 
designed by the personal view and values of healthcare professionals. These were 
done to be very subjective and paint a true picture of the reality of the situation 
in Nigeria. Also, it was related to a very high level of validity due to the information 
gotten from highly experienced professionals in the health system in Nigeria 
through the approach of interpretivism which was needed to obtain accurate 
results for the study. 
3.4 Research Strategy 
The strategy in place for the research was to access the awareness of the 
identification of falsified drugs, challenges, and viable improvement to fight the 
business of falsified drugs in Nigeria. As evidence of from the review conducted, 
it was discovered that there was no research showing at final solution faced by 
the issues of falsified drugs in Nigeria as it evident that one review or the other 
shows some slight variations because this is in comparison of the attitude, 
knowledge, and awareness of the use of available technology among groups in 
health professions in Nigeria. 
Some of the participants in this survey such as medical doctors, 
pharmacists, and some other forms of healthcare professionals who received the 
survey were previously informed the core purpose of this research work which was 
concerning a master's degree with Griffith college.  The question was then 
adjusted to a simpler version to aid easy answering. It was then administered over 
a different platform of health professionals in Nigeria such Pharmacy Student 
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association of Nigeria, Nigeria Association of veterinary medicines, Nigeria 
medical association, successfully practicing across all geographical regions of 
the country. 
3.5 Design of the questionnaire for Healthcare Professionals 
 The questionnaire is a method up of 33 questions which are divided into 6 
sections, the purpose of the study was design for the Nigerian healthcare setting 
specifically for healthcare professionals using an application called Microsoft 
Forms. This was then distributed randomly through the link electronically, and all 
survey was completed without the author's opinion. This situation encourages the 
idea of positivism so that respondents can fully express their opinion without any 
bias form. 
 The first part of the question started basically with an introduction to gain 
the consent of the respondents, allowing me to use their answer only for this 
purpose. The author assured them that the data that would be generated from 
this survey was in line with general data protection regulation (GDPR) and that 
their response was kept strictly confidential. The question must be answered 
before respondents can go ahead. 
3.6 Primary Data Collection 
The bellow is an outline of how the primary data would be collected. 
Section 1: simply contains respondent agreement which as to be agreed before 
commencing the survey. 
Section 2: it contains demographics information’s about the respondents 
Section 3: it consists of questions on the knowledge of healthcare professionals 
towards the falsified drug, how to detect falsified drugs, and the reporting system 
of falsified drugs. It also gives an insight into the different methods involved in 
identifying fake drugs as well as how effective the system is. 
Section 4: it involves questions on awareness of how falsified drug is been reported 
in Nigeria. It virtually consists of who is responsible for reporting fake drugs and 
should the system have been made compulsory or voluntary across all forms of 
medicinal products. It also asked questions on any evidence of falsified drugs for 
the past 1 year and how many were observed including reported to the right 
agency.  
Section 5: it contains questions that poised as challenges affecting healthcare 
professionals from identifying and reporting falsified drugs in Nigeria. It is 
encouraged to show the sole perception of healthcare professionals which limits 
them from achieving good identification rates 
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Section 6: This section consists of questions that are aimed at the recommended 
improvement that could be adopted to improve how to identify and report 
falsified drugs in Nigeria. 
3.7 Sources 
The questionnaire generated was distributed accordingly after the link was 
generated and send to different healthcare professionals’ platform in Nigeria. The 
author gathered data from about 131 respondents which are made up of 60 
medical doctors 36 pharmacists and 35 other health care professions. The author 
further utilized the Microsoft excel sheet on the result from the Microsoft forms to 
analyze the data which was collated. For further clarity, the author produced a 
pie and bar charts used to make comparisons where it matters. 
Furthermore, interviews through phone calls were then performed with 
highly experience healthcare professionals for a better understanding of the 
knowledge, awareness, challenges the professionals are facing in other to identify 
fake drugs. 
Selection of Medical Professional  
The author got in contact with different professional associations of 
healthcare in Nigeria to assist with the study, though it was difficult to get in touch 
with these bodies with constant perseverance there was some positive feedback. 
After several explanations on the reason for the study, the author received a 
recommendation from a well experienced and qualified pharmacist and 
medical doctor who was willing to participate in the interviews through a phone 
call. 
3.8 Access and Ethical Issues 
A summary of the research study was first introduced and provided to the 
healthcare professionals who showed interest in the survey and interviews as they 
were all duly informed about this study concerning the requirement by the author 
in partial fulfillment of the master program. Caution was also taken when 
structuring the questions for the survey as careful observation was done in other 
not to infringe on any personal space of the respondents. It was also noted to be 
voluntary participation and the respondent response would be anonymous and 








3.9 Inclusion and Exclusion Criteria 
 The professionals that were included in this research were medical doctors, 
pharmacists, and every other form of health care professional practicing in 
Nigeria. This set of people would have come in contact with drugs at any point in 
time in their professions. However, respondents who refused or decline to 
participate in this survey were automatically considered excluded from the study. 
Aside from this, no other form of criteria was considered in enrolling the 
respondents for this study and other future data analysis. 
 Furthermore, sample of letter of introduction was then attached to the 
questionnaire with the right answer for their informed consent before proceeding 
on the survey. Thus, it was solely on the discretion of the respondents to therefor 
take part or withdraw from the survey at their own will. Therefore, out of all the 
groups that got the links for the survey, those who decline to answer the 
questionnaire were encouraged to ignore the link, and those who answered and 
submitted the completed surveys were seen to have been voluntary. 
3.10 Conclusion 
For this survey, 33 questions were structured and distributed across different 
forms of healthcare professionals in Nigeria, both qualitative and quantitative 
approach was employed for this reason. A positivist philosophy was encouraged 
to hear to ensure an objective deduction from measurable facts was obtained. 
As part of the author's qualitative approach, a phone interview was carried out 
to get a better understanding and insight into the respondent's perception of the 
study. 
The data collected from the survey was then analyzed and comparison 
was made regarding the literature findings of the previous chapter. The author 
hoped to ascertain the attitude, knowledge, awareness of healthcare 
professionals concerning falsified drugs in Nigeria as well as any recommendable 
improvement that can assist in spontaneous identification and reporting in 
Nigeria. 
Thus, further analysis based on respondent responses that were generated 









CHAPTER 4: FINDING AND ANALYSIS 
4.1Overview  
This chapter provides answers which were generated from the 
questionnaire distributed online and examined accordingly. The result gotten 
from the data assisted the author to determine the awareness, knowledge, and 
challenges faced by healthcare professionals and provided the foundation for 
the author's conclusion of the research study needed to improve spontaneous 
identification and reporting. 
 Also following a phone interview conducted analysis was also drawn to 
establish any interaction with survey questionnaires, results, literature review, and 
the personal perspective of the author regarding the falsified drug in Nigeria. 
4.2 Demographic Data (Questions 1-6) 
4.2.1 Response Rate 
The questionnaire was distributed to 150 respondents which comprised 50 
doctors, 50 pharmacists, and 50 other health care professionals. A total of 131 
respondents who responded were 60 medical doctors, 36 pharmacists, and 35 
other healthcare professionals with a response rate of 87.3% response rate. Out of 
this response rate was made up of 49 respondents been women, 67 respondents 
been men and 15 of the respondents prefer not to avail their gender. 
The improved response rate in respective of the coronavirus pandemic 
facing the world was down to constant reminders through phone calls and text 
messages that were sent daily and also attaching the surveys to different online 
healthcare professionals’ platforms in Nigeria. It was also noticed that responses 






Fig 8a: Count of health professionals that responded 
 
Fig 8b: Percentage of health professionals that responded 
4.2.1 Level of Experience 
Because of the 131 respondents who completed the questionnaire, 43 of 
the respondents were aged between 20 to 30 years of age, 61 of respondents 
aged 31 to 40  while 21 of respondents were aged between 41 to 50, and 6 
respondents were aged between 51 and above. This shows predominantly young 
respondents responded to this questionnaire  
In terms of years of active practice in the health professions, of all of the 
healthcare professionals who participated in this survey 52 respondents as 6 to 
10years of experience, 44 respondents as about 1 to 5 years’ experience, 27 of 
the respondents as 10 years and above experience while only 8 respondents are 
practicing below one year. Hence the majority of the respondents are well 
experienced in their field of expertise. 




Medical Doctor Others Pharmacist
Total 60 35 36











Key: N= Northern; S=Southern, E=Eastern, W=Western; M=Male; Female; N=Neutral 
Table 5: Demographics 
4.3 Knowledge About Falsified Drug (Question 7-15) 
The response generated from this section is remarkable and unfortunate as 
the survey shows a varied response and a significant number of healthcare 
professionals claim they know how to detect falsified drugs. 
Question 7:  
In analyzing the question about how to detect falsified drugs in Nigeria, 62% 
of the respondents agreed that they know how to detect fake drug  (40 medical 
doctors, others 18, pharmacist 23) while 32%(13 medical doctors, others 17, 
pharmacist 12) of the respondents did not know. Only 6% of the healthcare 
professionals (7 medical doctors, 1 pharmacist) are not sure if they can detect 
fake drugs in Nigeria. 
Results show a very interesting statistics among respondents who 
participated in the survey, just 25% of medical doctor has a good knowledge of 
identifying fake drugs in comparison of a pharmacist who has 14% of identifying 
fake drugs and 11% for other forms of health care professionals. 
This confirms that there is still an average knowledge gap and even the 
medical doctor who prescribes this drug is still not above average in comparison 
to the pharmacist who has limited knowledge in identifying fake drugs as well as 
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Fig 8a: Count of Knowledge healthcare professionals in identifying falsified drugs 
 
Fig 8b Percentage of Knowledge among healthcare professionals in identifying 
the falsified drug in Nigeria 
Question 8 
Question 8 is a follow-up question to question 7 to have an idea of the 
source of knowledge among healthcare professionals. It was designed to have 
an idea where they get information about falsified drugs in Nigeria. A total no of 
14% respondents through the internet and social media (13 medical doctors, 5 
pharmacists), majority of the respondents get their information through articles 
published a figure about 70% (30 medical doctor, 29 pharmacists, 33 others) while 
about 16% of the respondents (17 medical doctor, 2 pharmacists, 2 medical 
doctors) gets information through verbal communication 
 This shows that a medical doctor is well informed in a slight comparison with 
the pharmacist and other healthcare professionals. It was analyzed that majority 
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of the healthcare professionals’ sources and rely on information from journals and 
articles published on information related to falsified drugs. However, despite the 
increase of social media awareness in the present time's healthcare professionals 
are not effectively using this means for spontaneous information to explore their 
knowledge  
 
Fig 9a: Count of different source of healthcare Knowledge 
 
Fig 9b: Percentage of different source of healthcare knowledge  
Question 9 
To determine the healthcare professional’s knowledge of which organization is 
responsible for handling pharmacovigilance in Nigeria, about 83% (42 medical 
doctor, 35 Others, 32 pharmacists) of the respondents identified the Nigerian 
Agency for Food and Drug Administration and Control (NAFDAC), 5% (medical 
doctor 6) of the respondent agreed that pharmacist council of Nigeria are in 
charge of pharmacovigilance while 12% (12 medical doctors, 4 Pharmacist) 
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selected World Health Organization to be in charge of pharmacovigilance in 
Nigeria. 
Thus the survey showed a significant result, while few medical doctors and 
pharmacist selected W.H.O has been in charge of pharmacovigilance in Nigeria 
as well as pharmacist council of Nigeria, a majority of the healthcare professionals 
acknowledged the fact that N.A.F.D.A.C is the primary regulatory agency in 
charge of pharmacovigilance in Nigeria which is correct. 
 
Fig 10a: Count of an agency responsible for pharmacovigilance in Nigeria 
 
Fig 10b: Percentage of an agency responsible for Pharmacovigilance 
Question 10 
In regards of responsibility of the healthcare professionals who should be in 
charge of reporting fake drugs in Nigeria, 11% (11 Medical doctor, 1Others, 2 
pharmacists)  of the respondents selected W.H.O as regulatory bodies in charge 
of reporting fake drugs in Nigeria, 75% (38 medical doctors, 33 others, 27 
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12%(8 Medical doctors, 1 other, 7 pharmacists) selected pharmacist council of 
Nigeria while a significant 2% (3 medical doctors) only selected N.M.A as a 
reporting agency.  
As depicted from the results it is obvious that majority of the healthcare 
professionals are very much aware of the agency in which they have to report 
any form of falsified drugs, however, it's still unusual that significant respondents of 
the pharmacist are still not aware of who to report fake drugs this is in contrast to 
other health care professionals who are majorly aware that all identified fake 
drugs needs to be reported to NAFDAC. Hence there is a poor familiarity of the 
pharmacist in reporting of identified fake drugs to the agency. 
 
Fig11a: Count of the agency is in charge of reporting fake drugs in Nigeria 
 
Fig11b: Percentage of the agency is in charge of reporting fake drugs in Nigeria 
Question 11 
This question is asking the healthcare professionals to identify which of the 
technology system of identifying falsified drugs are they familiar with. About 50% 
of the respondents (26 Medical doctors, 9 pharmacists, 31 others) selected Mobile 
Authentication system, 8% of the respondents (Medical doctors 2, pharmacist 8) 
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selected Radio frequency identification as a technology they are familiar with, 
25% (18 medical doctors, 2 others 13 pharmacists) are familiar with Black Eye 
technology, 16%(14 medical doctors, 6pharmacist)  of the respondents are 
familiar with truscan while just 1% of the respondents are familiar with all of the 
system. 
Therefore, results show that half of the respondents are familiar with the 
most advance and latest system provided by NAFDAC in identifying fake drugs. 
However, the only contrasting issues are that the pharmacist is a little unfamiliar 
with this technology. Another interesting statistic is the familiarization of the black 
eye technology by health care professionals, however, whatever technology that 
was asked the main aspect to point out here is that health care professionals are 
significantly aware of one or more of the system with the highest percentage on 
MAS. The next questions were to know if they use this system and how effective it 
is which would be answered in the next questions. 
 
Fig 12a: Count showing technology healthcare professionals are familiar with 
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Fig 12b: Percentage showing technology healthcare professionals are familiar 
with. 
Question 12 
This question was set up to ask healthcare professionals if this system 
provided by NAFDAC is in use. 48%( 24 medical doctors, 9 pharmacists 30 Others) 
are in use of any one of the systems to identify fake drugs while 52% (36medical 
doctors, 27pharmacist, 5 others) of the healthcare professionals who participated 
in this survey do not use any of the systems. 
This is evident that despite a majority of the health care acknowledging the 
fact that they are familiar with one or two of the technology available, results 
show that below-average healthcare professionals make use of this system with 
the pharmacist who prescribes this drug shows a relatively low number which is a 
really sad statistic to show. 
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Fig 13b: count of the frequency of the technology system been used. 
Question 13 
In a follow-up question, this question was asked to know how effective the 
system used to identify falsified drugs. 47% (32 medical doctors, 23 pharmacists, 7 
others) confirmed that the system is very effective, 44% (25medical doctor, 7 
pharmacists 27 others) are not sure if the system in place is effective while just 9% 
(4 Medical doctors, 6 pharmacists, 1 other) believed that the system is ineffective.   
 The result shows a significant below-average response. Just a few 
healthcare professionals believe that the system in place is effective, however, 
the population of healthcare is the medical doctor who acknowledges the fact 
that the system is effective in comparison to the pharmacist who doubts the 
system used in identifying falsified drugs.  
 











Fig14b: Count Showing the effectiveness of the system 
Question 14 
In other to know if healthcare professionals use this system to check for a 
falsified drug in Nigeria, respondents were then asked to confirm if they currently 
use this technology.47% of the respondents (25medical doctors, 9pharmacist, 27 
others) are currently using the system while  53% of the respondents (35 medical 
doctors, 27 Pharmacist, 8 Others) are currently not using any of this system. 
From the result, this shows a moderate usage of the technology as healthcare 
professionals are not putting the system in practice in their day to day activities. 
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Fig15b: Percentage of the rate of current usage of the system 
Question 15 
This question was to get the view of the respondents of the most significant 
criteria used in identifying falsified drugs spontaneously. 61% of the respondents 
(29 medical doctors, 20 pharmacists, 31 Others) admitted to all criteria from an 
adverse reaction, uncommon drug reaction and life-threatening reactions, 
21%(17 medical doctors, 8 pharmacists, 2Others) of the respondents admitted to 
checking for any life-threatening reactions to identify falsified drug, 14% of the 
respondents (10medical doctor, 2 others 6 pharmacists) only identify falsified 
drugs through uncommon drug reaction, while 5% of the respondents (4 medical 
doctors, 2 pharmacists) admitted to identifying fake drugs only through adverse 
reaction. 
The majority of healthcare professionals rely on a different form of reaction to 
identify fake drugs rather than relying on the technology to spontaneously identify 








Fig 16a: Percentage of most significant criteria for identifying fake drugs 
 
 
Fig 16b: Frequency of the most significant criteria for identifying fake drugs 
4.4 Awareness of Falsified Drug Reporting System (Questions 16-22) 
The responses of the section vary across the question to discover the awareness 
and as well as experience of healthcare professionals towards reporting of 
falsified drugs 
Question 16  
This question was asked to get the view of a healthcare professional who is 
responsible for reporting falsified drugs in Nigeria. 18% of the respondents (20 
medical doctors, 2pharmacist, 1others) selected medical doctors, 9% of the 
respondents (6 medical doctors, 6pharmacist) selected pharmacist, 54% (32 
medical doctors, 28pharmascit, 11 others) selected any of the above 18% of the 
respondents (1 medical doctor, 23 Others)selected others while just 1% (1 medical 
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Therefore, in analyzing which healthcare professionals were perceived to 
be majorly responsible, the majority of the healthcare respondents agreed that 
both the pharmacist, a medical doctor, as well as other forms of health care 
professionals, should be responsible for reporting of falsified drugs in Nigeria. 
 
Fig 17a: percentage of healthcare professionals responsible for reporting 
 
Fig17b: Count of health professionals responsible for reporting counterfeit drug 
Question 17 
This is a follow-up question to confirm if reporting of fake drug spontaneously 
should be made compulsory or voluntary.  An overwhelming 95% of respondents 
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Nigeria in comparison to 5% of respondents (5 medical doctors, 1pharmacist) who 
suggested it remain voluntary. 
Therefore, it is evident that all healthcare professionals would opt to make sure 
the reporting of a falsified drug be made compulsory like an obligation in Nigeria 
showing a favorable character to the importance of falsified drug reporting. 
 
Fig 18a: Count of healthcare opinion of reporting falsified drugs 
 
Fig18b: percentage showing if reporting should be made compulsory or voluntary 
Question 18 
This is also a follow-up question to determine the frequency in which observation 
of such falsified drug in Nigeria is observed by health care professionals, 54% of 
the respondents( 32 medical doctors, 13 pharmacists, 26 others) admitted having 
observed falsified drug, 37% of respondents (23 medical doctors, 19 pharmacists, 
7 others )had not observed any within this year. Only 8% of the respondents (5 
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All groups of health care professionals admitted having observed falsified drugs 
in the past 12 months, though it is only unusual for medical doctors and other 
healthcare professionals to observe more fake drugs than pharmacist within the 
past 12 months 
 
Fig 19a: Count of falsified drug notification in the past 1 year 
 
Fig 19b: percentage of a falsified drug for the past one year 
Question 19 
This question was asked in other to know how many falsified drugs have been 
discovered.5% of the respondents (5 Medical doctor, 1pharmacist, 1others) 
selected over hundred drugs discovered, 21%  of the respondents (2Medical 
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20% of respondents(11medical doctor, 7 Pharmacist, 8 Others) selected between 
51 to 74 drugs,  30% of the respondents (24 Medical doctor, 12Pharmacist, 3 
others) selected 26 to 50 drugs, 24% of respondents (18 Medical doctors, 14 
Pharmacist) selected less than 25 drugs discovered. 
As a follow-up from the response of the preceding question, this shows a 
moderate frequency of falsified drugs among health care professionals 
practicing in Nigeria, with pharmacists showing low frequency in their practice 
than medical doctors and other healthcare professionals. 
 
Fig 20a: Percentage of the frequency of falsified drug over the past 1 year 
 
Fig 20b: frequency of Falsified drug over the past 1 year 
Question 20 
As follow up question, 15% of the respondents (12 medical doctors, 1others, 7 
pharmacists) report falsified drugs to the Nigerian Pharmacovigilance center, 26% 
of respondents (20 Medical doctors, 9 Pharmacist, 5 Others) selected professional 
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manufacturers while 25% (2 medical doctors, 29 others 2 pharmacists) selected 
others  
As depicted from the response generated healthcare professionals are 
reporting falsified drugs to the wrong people. More respondents seem to report 
to the drug manufacturers instead of the regulatory agency who should sanction 
such a company for producing falsified drugs. There was a huge discrepancy 
among all groups of healthcare professionals concerning reporting any falsified 
drugs identified, this is because only a little percentage of the respondents report 
falsified drugs to the National Pharmacovigilance center. 
 
Fig 21a: percentage of an agency that receives falsified drug reports 
 
Fig 21b: Count of Agency that receives falsified drug report 
Question 21 
This question was to identify if there was any feedback from reporting any 
falsified drug. 42% of the respondent (21 medical doctor, 8 pharmacists, 26 others) 
receives feedback after reporting, 47% (32 Medical doctors, 22 pharmacists, 8 



















of the respondents (7 medical doctors, 6 Pharmacist, 1 Other) are not sure if they 
ever receive any form of Feedback after reporting. 
The result shows a poor follow up and response culture from a regulatory agency 
that is tasked with handling falsified drug reporting. This really and unfortunate 
situation as a regulatory agency does not give feedback to the professionals 
putting the health system in jeopardy. 
 
Fig 22a: percentage of any feedback received after reporting 
 
Fig 22b: Count of Falsified drug feedback report 
Question 22 
The question was asked to the respondents in improving their knowledge of 
the reporting system. A majority of the respondents 79% (45 Medical doctors, 
24Pharmacist, 34 others) admitted to upgrading their knowledge while 21% of the 
respondents (15 medical doctors, 12 pharmacists, 1 Other) are not in support of 
upgrading their knowledge about falsified drug reporting. 
Results confirmed that the majority of the healthcare professionals were 
open in upgrading their knowledge about falsified drug reporting system which is 




















Fig 23a: Count of upgrading knowledge about the reporting system 
 
Fig 23b: percentage of Upgrading knowledge of reporting system 
4.5 Challenges of Falsified Drug Reporting in Nigeria (Question 23-27) 
In analyzing the major challenges among healthcare professionals in 
reporting offenders in Nigeria, respondents were provided a list of options to 
choose from The author hopes to gain insight into the factor that serves as a 
current challenge in reporting those who are involved in the falsified drug 
business. Respondents were asked to either agree or disagree accordingly. 
The largest percentage of 94% of respondents agreed that though the laws were 
available there is not much enforcement on the existing laws regulating medicinal 
products in Nigeria while 5% of the respondents disagree with this claim and only 
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62% of the Healthcare professionals believed that ignorance among health care 
professionals is another factor that poses a great challenge of falsified drug 
reporting while 8% disagree with this claim, 31% remain unsure if this is an issue. 
60% of the respondents agreed that too much presence of Non-health care 
professionals in the drug business is a key factor, 30% remain unsure only 11% 
disagree with this claim. 
63% of healthcare professionals think that the high cost of good and efficient 
drugs are factors affecting falsified drug reporting in Nigeria, while 9% disagree 
with this claim, only 27% of the respondent disagrees 
Interestingly, 64% of the respondent agree to the fact that a high level of 
corruption in government policymakers is a major challenge the health system is 
facing, 24% remains neutral while 12% disagree outrightly. 
 
Fig 24: Count of Challenges of Falsified drug reporting in Nigeria 
4.6 IMPROVEMENT OF FALSIFIED DRUG IDENTIFICATION (Question 28-33) 
This entire section of the survey was drawn out in other to provide respondents 
considerations for the respondents to select from by either agreeing or 
disagreeing. The majority of the healthcare professionals agreed with all the 
recommendations proposed in the survey has been significant towards improving 
the falsified drug identification in Nigeria. 
A huge percentage of the respondents about 86% agree that continuous learning 
will create more awareness which is the key to improving falsified drug 




























53% of the respondents agree that current regulations should be reviewed and 
make necessary adjustment if necessary 38% remains unsure while 8% disagree. 
59% of the healthcare professionals believed that incorporating huge fines and 
sanctions for not identifying and reporting falsified drugs will help, 31% remain 
neutral while just 10% disagree. 
As part of the improvement strategy, about 62% of the respondent believed that 
incorporating a form of remuneration on each drug identified would help improve 
the system, 25% neutral with this claim, 13% disagrees. 
63% of the respondents agree that more awareness needs to be created to 
ensure both public and healthcare professionals are well aware of the system, 
24% are not sure if this would work while 12% feel awareness is not the problem. 
68% of the respondents agree that creating a special department task solely with 
the responsibility of falsified drug reporting in Nigeria would improve the health 
system, while 20% remains neutral to this claim only 12% disagrees outrightly. 
 
 































4.7 QUALITATIVE ANALYSIS 
4.7.1 Phone Interview with Medical Doctor (8 Years of Experience) 
The author explored the opportunity to speak with three contacts only, this 
is due to the global pandemic as getting an interview with healthcare 
professionals was very difficult at the time of writing this thesis. However, the author 
was able to get in touch with two medical doctors, on the challenges of 
spontaneous identifying falsified drugs in Nigeria. They gave consent for the 
interview on the condition of an anonymous status; however, they were both over 
40 years of age and had been in healthcare practice for a minimum of 8years. 
They both admitted having observed 10 falsified drugs in the last one year 
but can’t remember submitting any reports that same periods, but one of the 
doctors usually get in touch with the manufacturer alone ‘that drugs are either 
expired or outdated’. The other health care professionals only came in contact 
with falsified drugs if a patient comes back to him with an adverse event and they 
would check the drug to see if it is original through experience. They also agreed 
that they had never received any form of feedback from reporting any form of 
falsified drug as a regulatory agency is always slow in taken any form of decisive 
decision on the issues of the falsified drug. 
Both healthcare professionals were also asked to identify which system they are 
used to in terms of spontaneous identifying falsified drugs and reporting, they all 
believed that the Mobile Authentication Service system is the best option as it is 
very easy to operate and send information. Unfortunately, none of the healthcare 
professionals interviewed are familiar with the use of the systems to identify 
falsified drugs. They only believe in past knowledge about the drugs as well as 
experience on the drugs to check for any originality of the medicinal products 
that are suspected to be falsified. 
The specialists agreed that the entire regulations surrounding the falsified drug 
reporting and identification should be reviewed as a matter of urgency, they 
admitted that the process currently in place does not encourage spontaneous 
identification and feedbacks. Though they recommended it should be made 
compulsory and incentives should be made available to encourage upcoming 
doctors, they further stated that more seminars and education should be 
centered on identifying falsified drugs and heavy fines should be sanction on 





4.7.2 Phone Interview with a Pharmacist (8 Years’ Experience) 
 The author was able to get in touch with a pharmacist who is well 
experienced in community pharmacy. He works in a teaching hospital and has 
an outlet in a community-based pharmacy shop. The author got in touch with him 
and scheduled an urgent meeting since he was also busy due to the COVID-19 
situation in Nigeria. I needed to ascertain his professional view on challenges is a 
profession is facing on identifying falsified drugs as well as reporting drugs that are 
falsified. He also gave consent verbally for the interview and use any information 
obtained on the condition of anonymity as he would not want anything to affect 
his job in Nigeria. 
He understood the significance of good pharmacovigilance practice such 
as falsified drug identification in Nigeria health system. He admitted to regularly 
check if his drugs are falsified or original through experience and knowledge of 
the particular drugs. Thus, he has not reported any form of falsified drugs in the 
last 12 months of prescribing and selling any form of medicinal drugs. This goes to 
show why there is a very limited gap in the knowledge of pharmacy from the 
questionnaire in identifying fake drugs. However, he acknowledges the fact that  
regulatory authorities as the responsibility of handling falsified drugs, from his 
understanding pharmacist in hospitals were likely to report falsified drugs and get 
feedback than those having a community-based pharmacist shop as there was 
a more formal structure in a government based teaching hospital. 
On the issue of falsified drug reporting to the regulatory agency, he admitted 
being familiar with the mobile authentication service systems but complains of 
several issues with the technology. 
The excerpts below provide the missing link 
“The response time is very slow. You send the text with the numbers but for days 
you will be fortunate if you ever get any response.” 
“Network does not help at times as service can be very poor” 
“Most of the community-based pharmacist does not know the system and 
therefore we can not use what we do not know about” 
……extract from the interview 
 
On the issue of creating awareness to the healthcare professional who is not 
privileged with the knowledge of identifying falsified drugs. 
Below was his response 
77 
 
“From my point of view, the whole process of creating awareness by NAFDAC is 
shambolic. I only saw the advert ones on NTA( Nigeria Television Authority) but I 
must ask, how many people see the NTA every day, what is the fate of the rural 
dwellers where we have a higher population of our people…… an extract from 
an interview on this question 
Furthermore, he complained that the biggest challenge they have in the 
professions is the regulatory authorities who are in charge of the health system of 
Nigeria. The health system all round is suffering and would continue to suffer if the 
right regulations are not put in place to discourage falsified drug business. 
Below was his response 
“ The regulations surrounding fake drugs business in Nigeria is just too weak, I mean 
how can someone who makes a lot of money form fake drug business be 
penalized with a fine of just 500,000 naira or 15 years in prison if he does not pay 
up?. Our system is corrupt most of the government top officials are involved in 
most of all this business I can tell they always have special cut for containers 
brought into the country, so my brother the challenges of the Nigerian health 
system is beyond just identifying falsified drug alone….. an excerpt from the 
interview on this question. 
Another interesting fact he raised was a direct link between doctors and 
pharmacists just the way we have in Ireland. He complained that there is no 
platform where healthcare professionals interact with a pharmacist,  thus there is 
no form of correspondence between medical doctor and pharmacy in terms of 
drug prescription and dispensing. 
He also pointed out that most pharmacists would only report falsified drugs 
to the company to avoid losing business relationships as most drugs can be 
supplied to them on credits to resales and payback. Thus, in other not to lose the 
business relationship they only report falsified drugs to the manufacturer, and in 
most cases, they get feedback. 
He finally recommended increased awareness and outreach of the need to 
identify a falsified drug to discourage the rate of the falsified drug in the market. 
However, his major concern is the government of Nigeria they are very corrupt, 
and greedy they want to make money from any means available and the 







From the survey conducted it is evident that most healthcare professionals 
especially medical doctors and other forms of healthcare professionals are 
familiar with one or more systems of identification in relative comparison to the 
pharmacist who dispenses this drug. The majority of the pharmacy are only 
familiar with identifying fake drugs through adverse reactions, uncommon drug 
reactions, and life-threatening conditions. However medical doctor and other 
health professionals admitted to the use of mobile authentication system as a tool 
for identifying fake drugs, only an average number believed its effective due to 
some challenges they are always facing, despite this concern they all agree to 
the do better if proper training are made available to enlighten them constantly 
of the use of the system. 
NAFDAC through its National Pharmacovigilance center is in charge of 
reporting any form of falsified drugs and ensuring good pharmacovigilance 
practice such as ensuring the good and safe drug is available in the market, 
however they have failed in fulfilling their responsibility of raising awareness and 
making sure the right sanitization are made available to healthcare professionals. 
Most healthcare professionals source for information about falsified drugs through 
an article published and not through NAFDAC sanitization, as a result, most of 
them are not able to identify fake drugs if articles are not provided to enlighten 
their knowledge on the medicinal products. Very few healthcare professionals 
are aware of the guidelines and regulations of falsified drugs in Nigeria even those 
who are aware of the system send a report and rarely get an acknowledgment 
to know the next line of action which then results to the poor rate of reporting as 
healthcare professional are discourage to check if a drug is falsified or original. 
This study reveals that only a few of the respondents have ever identified 
fake drugs as well as reporting to the regulatory authorities. This is disheartening 
considering the continuous increase of fake drugs in the market, the preferred 
action was to return the falsified drug to the manufacturer or supplier rather than 
reporting to the regulatory authority or destroying. Such action would prevent any 
possible arrest or prosecution and any possible redistribution of such goods  
Healthcare professionals admitted that so many factors are contributing to the 
increase of falsified drug business in Nigeria ranging from healthcare professionals 
been ignorant, presence of non-health professionals in the business, corruption 
and high cost of drugs have all contributed in creating the challenges the health 
system is facing 
Falling the interview through a phone call the health professionals agreed that all 
they rely upon to identify falsified drug was based upon their knowledge gained 
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in one way or the other or by experience on the originality of the drug which is 
very risky since those who are involved in such trade usually change dynamics 
and can still penetrate the market. The pharmacist claimed that the main reason 
while there is so many lapses is down to the corruption in the government as 
regulations are not enforced, a patient can access over the counter drugs form 
an open market without any prescription.  
The majority of the healthcare professionals all agreed with the recommendation 
proposed in the survey while most of the healthcare professionals admitted 
creating a special department for easy reporting and feedback, incorporate a 
form of remuneration, as well as increase awareness, would encourage 
professionals to constantly monitor any form of medicinal drug. 
In the next chapter, further conclusions are made concerning the research 
questions asked earlier. A contrast would be made from the previous literature 




















CHAPTER 5: CONCLUSION 
5.1 Answering the three main research questions  
Question 1: Are healthcare professionals aware of the systems and methods 
available in identifying fake and counterfeit drugs, and its applicable guidelines 
in achieving a good pharmacovigilance practice. 
 
From the data and responses gathered in the survey as well as responses 
from well experienced medical doctors and pharmacists during an interview 
conducted over the phone, it is obvious that awareness among healthcare 
professionals towards the issue of falsified drugs in Nigeria is above average. Firstly, 
the awareness is solely attributed to articles been published with training obtained 
in colleges, they also rely on verbal communication among colleagues to be 
aware of a falsified drug in Nigeria and the system that is available for identifying 
fake drugs. 
Acceptance of different forms of the technology system by the 
respondents is moderate, however, the sole responsibility of creating awareness 
of falsified drug identification and good pharmacovigilance by the Nigerian 
Agency for Food and Drug Administration and Control through its National 
Pharmacovigilance centers still shows some relative gap. Though NAFDAC 
provided some structural advanced technology to identify falsified drugs 
spontaneously, despite this technology they have failed in converting these 
efforts to more improved awareness of the systems. A respondent who 
participated in the study encourages a better pharmacovigilance practice they 
recommended an upgrade in the way NAFDAC handles pharmacovigilance in 
Nigeria, they also encourage better feedback measures which should be 
targeted to healthcare professionals to bridge the gap created by the lack of use 
of the system 
 
Question 2: What are the major factors that serve as a threat to the effective 
reporting of offenders involved in the fake drug business? 
 
As a result of both questionnaires and phone interviews carried out, all 
groups of healthcare professionals attribute that the problem of Nigeria's health 
system is far beyond identifying falsified drugs in comparison with a country that 
has a better-organized health system. These include inadequate laws and poor 
enforcement of already existing rules and regulations, ignorance among 
healthcare professional, presence of Non-health care professionals in the health 




Some other factors that contributed to the issues of falsified drugs are as a 
result of a lack of acknowledgment or feedback from a regulatory agency when 
a report is sent to them. Some of the healthcare professionals complained that 
they rather send a report to the manufacturer who they deal with in business than 
sending to the regulatory agency who would not reply at all. Hence the burden 
this factor poses on the Nigerian health system cannot be overemphasized as in 
practice it is more serious than we can ever think of and there is no evidence of 
hope that the challenges are ending anytime soon. 
 
Question 3: What recommendation would help to improve fake drug 
identification and reporting among Nigerian healthcare concerning clinical 
practices. 
 
Since there is an average knowledge of the system in identifying falsified 
drug among healthcare professionals, with the medical doctor showing signs that 
they are more knowledgeable than the pharmacist, the regulation and also 
guideline should be improved in other to have a seamless flow of information 
thereby improving the rate of reporting of fake drugs in Nigeria. 
As shown through the survey and phone interviews all the healthcare 
workers agreed that the regulatory authorities should be very proactive by setting 
up different forms pf pharmacovigilance sessions and continuing education 
programs to create more awareness in the less privileged areas and sub rural 
regions of the country. There should be a radical increment in publicity on the 
system used in identifying falsified drugs and how it works including the 
accessibility of the reporting method to healthcare professionals 
Another interesting recommendation that was agreed upon by all forms of 
healthcare professionals is the review of current regulations of any form of falsified 
drugs in Nigeria, they all agreed that it should be a professional obligation among 
healthcare professionals. 
Furthermore, the healthcare professional all believed that creating a 
special department tasked with the responsibility of tracking and monitoring issues 
on any form of a falsified drug would encourage professionals to trust the system 
and report more falsified drugs. They all agreed that incorporate huge fines and 
sanctions for not identifying and reporting falsified drugs, including remuneration 
for every falsified drug reported, would also assist in discouraging any forms of 
falsified drugs. However, the author believed that incentive or remuneration 
should be in the form of awards or recognition rather than financial 
reimbursements to encourage good pharmacovigilance practice and drug 





5.2 Comparing and Contrasting Results from Primary and Secondary Research. 
The above-average of healthcare professionals who are knowledgeable 
enough for identifying falsified drugs through different sources aside from the 
technologies provided by NAFDAC which is an encouraging finding when 
compared with previous review. The zeal to upgrade their knowledge is also an 
encouraging aspect of these studies as they believed that learning is a 
continuous process. However, the lack of using the system provided by NAFDAC 
is relatively low as well as the current usage of the system, the result, when 
compared to similar studies, showed similar statistics. The observation has 
translated to a significant under-identification rate in comparison to the quantity 
of falsified medicinal drugs that are always available in Nigeria.  
Other similar figures in comparison with an initial study showed that the 
majority of the healthcare respondents considered the systems ineffective 
ranging from the poor acknowledgment and poor network infrastructures. The 
falsified drug is a global issue and the challenges vary across regions. The general 
factors ranging from inadequate, poor enforcement by regulatory authorities to 
general ignorance among healthcare professionals, high cost of good and 
efficient drugs as well as corruption in government policymakers are to some 
extent the same as noticed from previous studies in Nigeria and other countries 
battling with the issues of falsified drugs. (Ugochukwu, 2017) 
Other studies on issues of falsified drugs identification suggested that 
pharmacist is in a better position to identify this drug or either knowledgeable 
enough on falsified drugs. This study demonstrated that the medical doctor is 
more predisposed from all data gotten than other health care professionals. It's 
strange to see that medical doctor is better aware of this system provided by 
N.A.F.D.A.C  despite their busy schedule this goes to say there is a knowledge gap 
somewhere for all pharmacist and other healthcare professionals.  
Improving spontaneous identification and reporting of falsified drugs in 
Nigeria would greatly reduce the cost of the healthcare system in Nigeria which 
would further reduce the incidence of adverse events which is a result of falsified 
drugs consumed. While this study showed that all healthcare professionals agreed 
that more awareness needed to be created about falsified drug identification is 
also a similar aspect of previous studies. They need continuous learning programs 
in the form of a seminar to improve awareness, reviewing the current regulations, 
and see if any gaps are needed to close in comparison to other western countries 
like Ireland. Also as suggested by both groups of healthcare professionals falsified 
drug identification and reporting should be made compulsory and huge fines 
should be incorporated to anyone one who is found to be encouraging such 
business while previous studies indicate that remuneration is unethical, 
remunerations in form of excellence in work done could encourage such 
individual to continue identifying falsified drugs. (Chinwendu 2008) 
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5.3 Contributions and Limitation of the Research 
The study was finished at a decent time only after data was generated from 
the questionnaires from about 131 respondents despite the global coronavirus 
ravishing the country including phone call. The data was analyzed and 
transferred to excel formats and charts for easy understanding as well as bar 
charts. While most of the resources on falsified drugs focused on a single group or 
one of the systems of identifying falsified drugs, the research compared both 
medical doctors and pharmacists including other forms of healthcare 
professionals and responses came from across all 4 geographical zones of Nigeria. 
The principal limitation was relatively high for the author, firstly the global 
pandemic that shuts down the world discourage so many health care 
professionals from answering the survey as most of them were too busy fighting 
the pandemic. Also, factors such as the personal bias of the health professionals 
and high level of accuracy to attention to details could impact the interpretation 
of results obtained. The multiverse opinion of other non-respondents who also 
failed to respond to the question in the survey could have a huge impact on the 
outcomes of these studies. 
While the intuition into NAFDAC's regulatory responsibility towards 
pharmacovigilance provided an understanding towards the awareness of 
falsified drug identification as evident from NAFDAC online website, the author 
still believes that the roles and activities of its National pharmacovigilance centers 
are yet to be defined in relations to this topic. Therefore, it thinks that the 
challenges impacting falsified drug identification could differ across each area in 
Nigeria due to there level of education, experience, awareness, and economic 
activities that are taking place in this region. 
The author was privileged to know that the most agreeing responses from 
both groups concerning the contributory factor was inadequate laws and poor 
enforcement of already existing laws which was then followed by the high level 
of corruption in government policymakers which are charged with the 
responsibility of improving the health care system of the country. Despite the 
limited or averaged knowledge about falsified drug identification through this 
system, other factors were also met with more agreeing responses putting to the 
fact that there is a huge challenge in the health care system of Nigeria. Thus, 
further research can also be done on reducing this challenge. 
 
 
5.4 Recommendation (The Way Forward) 
In light of the findings, the recommendation below could be useful at various level 
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 There is an urgent need for the government to implement the provisions of 
the existing laws governing pharmaceutical products. 
 All NAFDAC laboratory should be well equipped and funded to analyze 
medicines suspected to be falsified and such facility could also have 
training facilities to regularly educate staff 
 Ensure that all forms of medicinal products are always scanned with the 
available systems. 
 Collaborate with other countries like Ireland to buy new ideas on how to 
detect fake drugs spontaneously 
 In most cases, the understanding, and practices of identifying falsified drug 
among health care professionals traditionally comes from laying down a 
foundation in undergraduate school, including knowledge gathered from 
training materials, articles, and verbal communication among colleagues 
and less form regulatory authority. There are so much knowledge resources 
available on the website in regards to falsified drugs and its growing trends 
but unfortunately, health care professionals are either not interested or 
have refused to use the system therefore in other to create more 
awareness, the awareness programs should be remodified by keeping the 
healthcare professionals informed on a regular base. 
 Furthermore, there should be a review of the course content on all 
healthcare professional course outlines such as tutorials or seminars 
specifically for falsified drugs to be included in the final stage of their 
practice or studies. It should stress the importance of not being able to 
identify falsified drugs and the penalty involved if such medicinal drugs 
were prescribed or dispensed by any of the healthcare professionals. 
 Also, most healthcare institutions should be able to establish an institution 
specifically designed to test the quality of drugs. This will help to create 
awareness and improve student knowledge of the use of the system for 









 Creating a good medicinal distribution that is licensed for effective 
supervision. This can be made possible through government support and 
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creating a special unit called Good Distribution Practice (GDP) that 
monitors drug distribution such as the HPRA in Ireland 
 Regular training especially to law enforcement officers, this will help NFDAC 
and military personnel in combating fake drugs  
 The tariff placed for original drug imported should be reviewed because it 
creates a large cost in the markets as importers want to make back the 
money lost in registration. 
 Tight security at all ports of entries in the country should be encouraged to 
curb the activities of the falsified drug coming into the country. 
 A mini laboratory should be established at each state where NAFDAC is 
present, this will effectively reduce the stress of staff that has to travel long 
distance with goods for registration 
 A planned routine inspection visits on imported products, this is because a 
five years wait is too long to believe that industry still maintains good 
manufacturing practice as seen during the first part of the inspection. 
 There is also a need for the agency to develop a better plan in promoting 
awareness among healthcare professionals as well as the public since 
these drug makers have become sophisticated in their activities. 
 To make staff incentive and salary commensurate to what is obtained with 
other big government agencies and recognition in the form of 
professional’s awards should be encouraged. 
 Creating a good working and comfortable environment for staff will 
encourage effectiveness all around  
For Government: 
 There is an urgent need for the federal government to have well-defined 
drug laws that must be effectively implemented by all government 
administration that comes to power and all arm of the legislation such as 
the judiciary that handles cases of violators without any form of der and 
trembles because it is so sad that agency makes so much efforts to arrest 
offenders but cases go to court and get denied and dismissed due to 
government interference. 
 The judiciary should stop any form of delay in the prosecution of drug 
offenders and adjournment of cases that requires immediate action. 
 The use of non-healthcare professionals in business should be reviewed. 
Since consumers would always buy from them the government should buy 
the idea of training them on basic ethics as it relates to pharmaceutical 
drugs 
 
5.5 Recommendation for Future Research 
Curbing the effect of a falsified drug in Nigeria is very difficult and the 
author believes that everybody should be involved in fighting this crime. 
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Therefore, in doing this further research needs to be carried on the public 
participation in spontaneously identifying falsified drugs. Since patients in the 
hospital, including those individuals who still buy drugs from the open market in 
Nigeria, are the critical groups who are been administered these drugs, they 
should be able to identify and report any drug suspected to be falsified. Also, 
research can be expanded to include nurses to improve spontaneous 
identification this can then be compared with the medical doctor's, pharmacist 
to ascertain their awareness about identifying fake drugs in Nigeria since they are 
also the first line in administering this drugs to the patient in hospitals as well as a 
nursing home. 
Furthermore, future research can be carried out for falsified drug 
identification and reporting with a major focus on each particular states of the 
country. The author believes that results can be compared to the challenges 
each state is facing the challenges of curbing of falsified drugs in the states. 
Results can then be compared and those with fewer challenges can offer to 
advise that can be of help to other states for safe practices of drugs in the states. 
A country like Ireland with a well-defined system in relations to health 
systems, a future study can be carried out with the regulatory authority of Ireland 
inform of interviews and possible seminars and meeting to compare the 
challenges both countries are facing and how they have been able to manage 
their situation better than Nigeria. The country can learn how to upgrade its 
pharmacovigilance practice from understudying Ireland, practicing good 
pharmacovigilance models is a critical issue that healthcare professionals can 
benefit from Ireland. 
Lastly, a future study can be carried out on the use of the internet and social 
media as an avenue to increase the knowledge and awareness of falsified drug 
identification in Nigeria. This is because social media has become inextricably 
integrated into every individual life, most of us rely so much on Facebook, Twitter, 
Instagram, YouTube including Pinterest to keep up with different forms of 
information. From the data gathered it was evident that healthcare professionals 










5.6 Future Speculation of Nigerian Pharmaceutical Sector 
By now is no news again that the Nigerian pharmaceutical industry is 
regarded as an African emerging economy with a huge prospect and expanding 
population which gives various investors in the sectors enormous opportunities. 
However, in the area of healthcare, numerous challenges as dwindle the sector 
which makes the sector largely untapped. 
However, there is some major development that is been speculated to 
ensure the best international practices in the pharmaceuticals and production 
capabilities of the sector. One of the key areas that the pharmaceutical 
regulations are speculating is to improve the current methods of making drugs 
which were based on a labor-intensive strategy that has been in place since the 
70s. the regulations are trying to enforce less human interference in the 
production of drugs which is prone to contamination. Another aspect is to move 
away from over-dependence on the importation of machinery, active 
ingredients, raw materials, and unregulated drug distribution which has been 
affecting the pharmaceutical industry in Nigeria. 
Furthermore one of the major areas that would see developments soon is 
the local Pharmaceutical manufacturing as the federal government through the 
Central Bank of Nigeria is set to increase funding by authorizing all money bank 
to ensure that 60% of foreign exchange sales goes to local manufacturers as this 
is to ensure that the sector is becoming very attractive and competitive in other 
to meet international world standards. Though the author knows this is all 
speculations it is possible if these laws and regulations are implemented 
accordingly. 
5.7 Final Conclusion 
in concluding this study on the challenges, awareness, and knowledge of 
healthcare professionals in spontaneous identification of falsified drugs in Nigeria, 
all the participants in this study all agreed that the factors contributing to the 
challenges of spontaneous identification of falsified drugs in Nigeria range from 
inadequate laws, ignorance among healthcare professionals, high level of 
corruption among government officials who make this law. The laws governing 
the production, sale, distribution, importation, and exportation of drugs are not 
adequate to control the illegal sale of drugs in Nigeria. This comes as a result of 
the policymakers been corrupt as they take so much bribe to only make laws 
without enforcing it, a situation like this makes it difficult for healthcare officials to 
put all effort in making sure no fake drugs passes through them. 
Why the healthcare professionals all agreed that the system of identified 
falsified rugs should be made compulsory, the author concludes that the Nigerian 
Healthcare professionals still need to understand the huge health problem of 
consuming fake drugs. This is a result of the data that shows that only 62% of the 
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respondents know how to detect the falsified drug in comparison with the number 
of drugs that floods the Nigerian market. A higher percentage of the respondents 
sourced their knowledge form articles published in respect of falsified drugs and 
of all the system mentioned for identifying fake drugs  MAS may be a successful 
tool in identifying and reporting falsified drugs due to how users perceived it to 
be. This is because it is compatible with the use of a mobile phone for text 
messaging and quick response to authentication. However not all health 
professionals can use this system to identify fake drugs either they believed the 
system is ineffective or they believed in past knowledge and experience for 
identifying fake drugs. Therefore, the author concludes that the knowledge of 
healthcare professionals in identifying falsified drugs is above averaged. 
A higher percentage of healthcare professionals believed that continuous 
learning and more education programs would help to increase the awareness of 
falsified drug identification in Nigeria. Thus, this shows the major willingness of 
healthcare professionals to further learn various ways to help improve 
pharmacovigilance and ensure drug safety in the country. The author also notes 
that various data from each question suggest that the pharmacist are lacking 
behind and no wonder they require more education to be able to identify fake 
drugs. There is a huge gap created in the relation of overall data provided on 
each question as a pharmacist was shown to have low responses in comparison 
to other healthcare professionals.  
Also, the author believed that a form of incentive in form of professional 
recognition should be made available for everyone contributing to the fight 
against falsified drugs in the country as this would go a long way in encouraging 
other healthcare professionals. The government also needs to fund NAFDAC and 
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